Identification	O
and	O
characterization	O
of	O
an	O
Alu-containing	B-DNA
,	I-DNA
T-cell-specific	I-DNA
enhancer	I-DNA
located	O
in	O
the	O
last	O
intron	B-DNA
of	O
the	O
human	B-DNA
CD8	I-DNA
alpha	I-DNA
gene	I-DNA
.	O

Expression	O
of	O
the	O
human	B-DNA
CD8	I-DNA
alpha	I-DNA
gene	I-DNA
is	O
restricted	O
to	O
cells	O
of	O
the	O
lymphoid	B-cell_type
lineage	I-cell_type
and	O
developmentally	O
regulated	O
during	O
thymopoiesis	O
.	O

As	O
an	O
initial	O
step	O
towards	O
understanding	O
the	O
molecular	O
basis	O
for	O
tissue-specific	O
expression	O
of	O
this	O
gene	O
,	O
we	O
surveyed	O
the	O
surrounding	O
chromatin	O
structure	O
for	O
potential	O
cis-acting	B-DNA
regulatory	I-DNA
regions	I-DNA
by	O
DNase	B-protein
I	I-protein
hypersensitivity	O
mapping	O
and	O
found	O
four	O
hypersensitive	O
sites	O
,	O
three	O
of	O
which	O
were	O
T	O
cell	O
restricted	O
.	O

By	O
using	O
a	O
reporter-based	O
expression	O
approach	O
,	O
a	O
T-cell-specific	B-DNA
enhancer	I-DNA
was	O
identified	O
by	O
its	O
close	O
association	O
with	O
a	O
prominent	O
T-cell-restricted	B-DNA
hypersensitive	I-DNA
sites	I-DNA
in	O
the	O
last	O
intron	O
of	O
the	O
CD8	B-DNA
alpha	I-DNA
gene	I-DNA
.	O

Deletion	O
studies	O
demonstrated	O
that	O
the	O
minimal	O
enhancer	O
is	O
adjacent	O
to	O
a	O
negative	O
regulatory	O
element	O
.	O

DNA	O
sequence	O
analysis	O
of	O
the	O
minimal	B-DNA
enhancer	I-DNA
revealed	O
a	O
striking	O
cluster	O
of	O
consensus	B-DNA
binding	I-DNA
sites	I-DNA
for	O
Ets-1	B-protein
,	I-protein
TCF-1	I-protein
,	I-protein
CRE	I-protein
,	I-protein
GATA-3	I-protein
,	I-protein
LyF-1	I-protein
,	I-protein
and	I-protein
bHLH	I-protein
proteins	I-protein
which	O
were	O
verified	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

In	O
addition	O
,	O
the	O
5	B-DNA
'	I-DNA
end	I-DNA
of	O
the	O
enhancer	B-DNA
was	O
composed	O
of	O
an	O
Alu	O
repeat	O
which	O
contained	O
the	O
GATA-3	B-DNA
,	I-DNA
bHLH	I-DNA
,	I-DNA
and	I-DNA
LyF-1	I-DNA
binding	I-DNA
sites	I-DNA
.	O

Site-directed	O
mutation	O
of	O
the	O
Ets-1	B-DNA
and	I-DNA
GATA-3	I-DNA
sites	I-DNA
dramatically	O
reduced	O
enhancer	O
activity	O
.	O

The	O
functional	O
importance	O
of	O
the	O
other	O
binding	O
sites	O
only	O
became	O
apparent	O
when	O
combinations	O
of	O
mutations	O
were	O
analyzed	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
the	O
human	B-DNA
CD8	I-DNA
alpha	I-DNA
gene	I-DNA
is	O
regulated	O
by	O
the	O
interaction	O
of	O
multiple	O
T-cell	B-protein
nuclear	I-protein
proteins	I-protein
with	O
a	O
transcriptional	O
enhancer	O
located	O
in	O
the	O
last	O
intron	B-DNA
of	O
the	O
gene	O
.	O

Comparison	O
of	O
the	O
CD8	B-DNA
alpha	I-DNA
enhancer	I-DNA
with	O
other	O
recently	O
identified	O
T-cell-specific	B-DNA
regulatory	I-DNA
elements	I-DNA
suggests	O
that	O
a	O
common	O
set	O
of	O
transcription	B-protein
factors	I-protein
regulates	O
several	O
T-cell	B-DNA
genes	I-DNA
.	O

MoLEcULarR	NULL
anp	NULL
CELLULAR	NULL
BroLoogy	NULL
,	NULL
Nov.	NULL
1993	NULL
,	NULL
p.	NULL
7056-7070	NULL
0270-7306/93/117056-15	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Identification	NULL
and	NULL
Characterization	NULL
of	NULL
an	NULL
Alu-Containing	NULL
,	NULL
T-Cell-Specific	NULL
Enhancer	NULL
Located	NULL
in	NULL
the	NULL
Last	NULL
Intron	NULL
of	NULL
the	NULL
Human	NULL
CD8a	NULL
Gene	NULL
JOHN	NULL
E.	NULL
HAMBOR	NULL
,	NULL
*	NULL
JOHN	NULL
MENNONE	NULL
,	NULL
*	NULL
MICHAEL	NULL
E.	NULL
COON	NULL
,	NULL
't	NULL
JEFFREY	NULL
H.	NULL
HANKE	NULL
,	NULL
'	NULL
anp	NULL
PAULA	NULL
KAVATHAS*	NULL
>	NULL
**	NULL
Department	NULL
of	NULL
Molecular	NULL
Genetics	NULL
and	NULL
Protein	NULL
Chemistry	NULL
,	NULL
Pfizer	NULL
Central	NULL
Research	NULL
,	NULL
Groton	NULL
,	NULL
Connecticut	NULL
06340	NULL
,	NULL
and	NULL
Departments	NULL
of	NULL
Immunobiology	NULL
,	NULL
``	NULL
Genetics	NULL
,	NULL
``	NULL
and	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
**	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
333	NULL
Cedar	NULL
Street	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
208035	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Connecticut	NULL
06520-8035	NULL
Received	NULL
14	NULL
December	NULL
1992/Returned	NULL
for	NULL
modification	NULL
9	NULL
April	NULL
1993/Accepted	NULL
9	NULL
August	NULL
1993	NULL
Expression	NULL
of	NULL
the	NULL
human	NULL
CDS	NULL
gene	NULL
is	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
lymphoid	NULL
lineage	NULL
and	NULL
developmentally	NULL
regulated	NULL
during	NULL
thymopoiesis	NULL
.	NULL

As	NULL
an	NULL
initial	NULL
step	NULL
towards	NULL
understanding	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
,	NULL
we	NULL
surveyed	NULL
the	NULL
surrounding	NULL
chromatin	NULL
structure	NULL
for	NULL
potential	NULL
cis-acting	NULL
regulatory	NULL
regions	NULL
by	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
mapping	NULL
and	NULL
found	NULL
four	NULL
hypersensitive	NULL
sites	NULL
,	NULL
three	NULL
of	NULL
which	NULL
were	NULL
T	NULL
cell	NULL
restricted	NULL
.	NULL

By	NULL
using	NULL
a	NULL
reporter-based	NULL
expression	NULL
approach	NULL
,	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
was	NULL
identified	NULL
by	NULL
its	NULL
close	NULL
association	NULL
with	NULL
a	NULL
prominent	NULL
T-cell-restricted	NULL
hypersensitive	NULL
sites	NULL
in	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
CD8a	NULL
«	NULL
gene	NULL
.	NULL

Deletion	NULL
studies	NULL
demonstrated	NULL
that	NULL
the	NULL
minimal	NULL
enhancer	NULL
is	NULL
adjacent	NULL
to	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
.	NULL

DNA	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
revealed	NULL
a	NULL
striking	NULL
cluster	NULL
of	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
Ets-1	NULL
,	NULL
TCF-1	NULL
,	NULL
CRE	NULL
,	NULL
GATA-3	NULL
,	NULL
LyF-1	NULL
,	NULL
and	NULL
bHLH	NULL
proteins	NULL
which	NULL
were	NULL
verified	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
enhancer	NULL
was	NULL
composed	NULL
of	NULL
an	NULL
4/u	NULL
repeat	NULL
which	NULL
contained	NULL
the	NULL
GATA-3	NULL
,	NULL
bHLH	NULL
,	NULL
and	NULL
LyF-1	NULL
binding	NULL
sites	NULL
.	NULL

Site-directed	NULL
mutation	NULL
of	NULL
the	NULL
Ets-1	NULL
and	NULL
GATA-3	NULL
sites	NULL
dramatically	NULL
reduced	NULL
enhancer	NULL
activity	NULL
.	NULL

The	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
other	NULL
binding	NULL
sites	NULL
only	NULL
became	NULL
apparent	NULL
when	NULL
combinations	NULL
of	NULL
mutations	NULL
were	NULL
analyzed	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
human	NULL
CD8a	NULL
«	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
multiple	NULL
T-cell	NULL
nuclear	NULL
proteins	NULL
with	NULL
a	NULL
transcriptional	NULL
enhancer	NULL
located	NULL
in	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
CD8	NULL
«	NULL
enhancer	NULL
with	NULL
other	NULL
recently	NULL
identified	NULL
T-cell-specific	NULL
regulatory	NULL
elements	NULL
suggests	NULL
that	NULL
a	NULL
common	NULL
set	NULL
of	NULL
transcription	NULL
factors	NULL
regulates	NULL
several	NULL
T-cell	NULL
genes	NULL
.	NULL

The	NULL
T-lymphocyte	NULL
differentiation	NULL
marker	NULL
CD8	NULL
identifies	NULL
a	NULL
distinct	NULL
T-cell	NULL
subset	NULL
which	NULL
can	NULL
be	NULL
triggered	NULL
to	NULL
express	NULL
cytotoxic	NULL
and/or	NULL
suppressor	NULL
activity	NULL
upon	NULL
recognition	NULL
of	NULL
antigenic	NULL
peptides	NULL
presented	NULL
in	NULL
the	NULL
context	NULL
of	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
molecules	NULL
(	NULL
46	NULL
,	NULL
62	NULL
,	NULL
75	NULL
)	NULL
.	NULL

Expressed	NULL
on	NULL
the	NULL
T-cell	NULL
surface	NULL
as	NULL
either	NULL
an	NULL
«	NULL
/a	NULL
homodimer	NULL
or	NULL
«	NULL
/B	NULL
heterodimer	NULL
,	NULL
CD8	NULL
is	NULL
capable	NULL
of	NULL
direct	NULL
extracellular	NULL
interaction	NULL
with	NULL
the	NULL
«	NULL
3	NULL
domain	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
(	NULL
12	NULL
,	NULL
60	NULL
,	NULL
63	NULL
,	NULL
68	NULL
)	NULL
and	NULL
intracellular	NULL
association	NULL
with	NULL
the	NULL
tyrosine	NULL
kinase	NULL
p56	NULL
``	NULL
(	NULL
3	NULL
,	NULL
8	NULL
)	NULL
,	NULL
assisting	NULL
both	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
in	NULL
antigen	NULL
recognition	NULL
and	NULL
the	NULL
CD3	NULL
complex	NULL
in	NULL
signal	NULL
trans-duction	NULL
.	NULL

Thus	NULL
,	NULL
CD8	NULL
serves	NULL
as	NULL
an	NULL
integral	NULL
part	NULL
of	NULL
a	NULL
complex	NULL
recognition/response	NULL
apparatus	NULL
which	NULL
functions	NULL
to	NULL
initiate	NULL
antigen-driven	NULL
activation	NULL
of	NULL
mature	NULL
effector	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
periphery	NULL
as	NULL
well	NULL
as	NULL
differentiation	NULL
of	NULL
immature	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Tissue-specific	NULL
expression	NULL
of	NULL
CD8	NULL
is	NULL
under	NULL
precise	NULL
developmental	NULL
control	NULL
.	NULL

When	NULL
bone	NULL
marrow-derived	NULL
precursor	NULL
cells	NULL
begin	NULL
the	NULL
process	NULL
of	NULL
thymopoiesis	NULL
,	NULL
a	NULL
panel	NULL
of	NULL
T-cell-specific	NULL
genes	NULL
(	NULL
TCR	NULL
,	NULL
CD2	NULL
,	NULL
CD3	NULL
,	NULL
and	NULL
CD4	NULL
)	NULL
including	NULL
CD8a	NULL
«	NULL
and	NULL
CD8f	NULL
are	NULL
coordinately	NULL
expressed	NULL
in	NULL
a	NULL
defined	NULL
temporal	NULL
sequence	NULL
(	NULL
10	NULL
,	NULL
32	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Early	NULL
in	NULL
this	NULL
differentiation	NULL
pathway	NULL
,	NULL
the	NULL
most	NULL
immature	NULL
T	NULL
cells	NULL
(	NULL
CD4~	NULL
CD8~T	NULL
)	NULL
progress	NULL
to	NULL
an	NULL
intermediate	NULL
phenotype	NULL
expressing	NULL
both	NULL
CD4	NULL
and	NULL
CD8	NULL
.	NULL

These	NULL
CD4*	NULL
CD8*	NULL
T	NULL
cells	NULL
,	NULL
representing	NULL
the	NULL
majority	NULL
of	NULL
thymocytes	NULL
,	NULL
subsequently	NULL
undergo	NULL
a	NULL
further	NULL
differentiation	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Connecticut	NULL
,	NULL
Storrs	NULL
,	NULL
CT	NULL
06269	NULL
.	NULL

7056	NULL
step	NULL
in	NULL
which	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
TCR	NULL
repertoire	NULL
is	NULL
selected	NULL
by	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
pressures	NULL
,	NULL
a	NULL
process	NULL
mediated	NULL
,	NULL
in	NULL
part	NULL
,	NULL
by	NULL
CD8	NULL
(	NULL
1	NULL
,	NULL
19	NULL
,	NULL
35	NULL
,	NULL
70	NULL
,	NULL
84	NULL
)	NULL
.	NULL

The	NULL
outcome	NULL
of	NULL
this	NULL
developmental	NULL
event	NULL
is	NULL
the	NULL
maturation	NULL
of	NULL
T	NULL
cells	NULL
which	NULL
express	NULL
either	NULL
CD4	NULL
or	NULL
CD8	NULL
,	NULL
but	NULL
not	NULL
both	NULL
.	NULL

These	NULL
mature	NULL
cells	NULL
,	NULL
representing	NULL
for	NULL
the	NULL
most	NULL
part	NULL
either	NULL
the	NULL
MHC	NULL
class	NULL
II-restricted	NULL
helper	NULL
subset	NULL
(	NULL
CD4+*	NULL
CD8~	NULL
)	NULL
or	NULL
the	NULL
MHC	NULL
class	NULL
TI-restricted	NULL
cytotoxic/suppressor	NULL
subset	NULL
(	NULL
CD4~	NULL
CD8*	NULL
)	NULL
,	NULL
exit	NULL
the	NULL
thymus	NULL
and	NULL
seed	NULL
the	NULL
peripheral	NULL
lymphoid	NULL
tissues	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
thymus-dependent	NULL
T	NULL
cells	NULL
which	NULL
generally	NULL
express	NULL
both	NULL
CD8a	NULL
«	NULL
and	NULL
CD8B	NULL
during	NULL
at	NULL
least	NULL
one	NULL
stage	NULL
of	NULL
their	NULL
development	NULL
,	NULL
extrathymically	NULL
derived	NULL
intraepithelial	NULL
lymphocytes	NULL
and	NULL
natural	NULL
killer	NULL
lymphocytes	NULL
express	NULL
only	NULL
CD8a	NULL
(	NULL
36	NULL
,	NULL
62	NULL
,	NULL
77	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
expression	NULL
of	NULL
CD8a	NULL
and	NULL
CD8B	NULL
may	NULL
be	NULL
both	NULL
coordinately	NULL
and	NULL
independently	NULL
regulated	NULL
,	NULL
in	NULL
that	NULL
both	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
expressed	NULL
at	NULL
distinct	NULL
stages	NULL
of	NULL
thymic	NULL
ontogeny	NULL
,	NULL
yet	NULL
only	NULL
CD8a	NULL
is	NULL
expressed	NULL
in	NULL
specific	NULL
subsets	NULL
of	NULL
extrathymic	NULL
lymphocytes	NULL
.	NULL

While	NULL
the	NULL
function	NULL
of	NULL
CD8	NULL
and	NULL
its	NULL
differential	NULL
expression	NULL
pattern	NULL
have	NULL
been	NULL
extensively	NULL
studied	NULL
,	NULL
the	NULL
mechanisms	NULL
governing	NULL
transcription	NULL
of	NULL
both	NULL
the	NULL
CD8a	NULL
«	NULL
and	NULL
CD8B	NULL
genes	NULL
during	NULL
these	NULL
developmental	NULL
processes	NULL
remain	NULL
poorly	NULL
under-stood	NULL
.	NULL

Since	NULL
these	NULL
two	NULL
distinct	NULL
genes	NULL
are	NULL
closely	NULL
linked	NULL
on	NULL
human	NULL
chromosome	NULL
2	NULL
(	NULL
7	NULL
,	NULL
56	NULL
)	NULL
and	NULL
on	NULL
mouse	NULL
chromosome	NULL
6	NULL
(	NULL
25	NULL
)	NULL
,	NULL
they	NULL
may	NULL
be	NULL
coordinately	NULL
regulated	NULL
by	NULL
a	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
15	NULL
,	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
genes	NULL
may	NULL
also	NULL
be	NULL
independently	NULL
controlled	NULL
,	NULL
given	NULL
that	NULL
only	NULL
CD8a	NULL
«	NULL
is	NULL
expressed	NULL
in	NULL
some	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
each	NULL
gene	NULL
appears	NULL
to	NULL
have	NULL
its	NULL
own	NULL
promoter	NULL
element	NULL
,	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
studies	NULL
determining	NULL
the	NULL
transcriptional	NULL
start	NULL
sites	NULL
for	NULL
each	NULL
gene	NULL
(	NULL
57-59	NULL
,	NULL
72	NULL
)	NULL
.	NULL

In	NULL
light	NULL
of	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
the	NULL
recent	NULL
observations	NULL
that	NULL
the	NULL
tissue-specific	NULL
enhancers	NULL
of	NULL
other	NULL
T-cell-restricted	NULL
genes	NULL
such	NULL
as	NULL
TCR	NULL
,	NULL
CD2	NULL
,	NULL
CD3	NULL
,	NULL
and	NULL
CD4	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
20	NULL
,	NULL
23	NULL
,	NULL
31	NULL
,	NULL
37	NULL
,	NULL
38	NULL
,	NULL
41	NULL
,	NULL
44	NULL
,	NULL
45	NULL
,	NULL
50	NULL
,	NULL
51	NULL
,	NULL
64-66	NULL
,	NULL
69	NULL
,	NULL
74	NULL
,	NULL
76	NULL
,	NULL
79	NULL
,	NULL
81	NULL
)	NULL
bind	NULL
a	NULL
common	NULL
set	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
some	NULL
of	NULL
which	NULL
are	NULL
found	NULL
only	NULL
in	NULL
lymphoid	NULL
cells	NULL
)	NULL
,	NULL
CD8	NULL
expression	NULL
may	NULL
also	NULL
be	NULL
controlled	NULL
by	NULL
a	NULL
similar	NULL
T-cell-specific	NULL
enhancer	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
may	NULL
influence	NULL
transcription	NULL
of	NULL
the	NULL
CD8	NULL
«	NULL
and	NULL
CD8B	NULL
genes	NULL
,	NULL
since	NULL
CD8	NULL
expression	NULL
is	NULL
down-regulated	NULL
as	NULL
helper	NULL
T	NULL
cells	NULL
(	NULL
CD4*	NULL
CD8~	NULL
)	NULL
mature	NULL
at	NULL
the	NULL
final	NULL
stage	NULL
of	NULL
thymic	NULL
ontogeny	NULL
.	NULL

To	NULL
define	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
regulate	NULL
CD8	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
searched	NULL
for	NULL
potential	NULL
regulatory	NULL
regions	NULL
by	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
mapping	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
T-cell-specific	NULL
transcriptional	NULL
regulatory	NULL
region	NULL
found	NULL
in	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
«	NULL
gene	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
this	NULL
region	NULL
contains	NULL
Alu	NULL
repeats	NULL
and	NULL
a	NULL
cluster	NULL
of	NULL
motifs	NULL
sharing	NULL
homology	NULL
with	NULL
previously	NULL
described	NULL
core	NULL
enhancers	NULL
for	NULL
other	NULL
T-cell-specific	NULL
genes	NULL
(	NULL
20	NULL
,	NULL
23	NULL
,	NULL
31	NULL
,	NULL
38	NULL
,	NULL
41	NULL
,	NULL
44	NULL
,	NULL
45	NULL
,	NULL
50	NULL
,	NULL
51	NULL
,	NULL
64-66	NULL
,	NULL
74	NULL
,	NULL
76	NULL
,	NULL
81	NULL
)	NULL
.	NULL

Preliminary	NULL
characterization	NULL
of	NULL
this	NULL
enhancer	NULL
indicates	NULL
that	NULL
a	NULL
functional	NULL
hierarchy	NULL
exists	NULL
among	NULL
the	NULL
individual	NULL
cis-acting	NULL
elements	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
.	NULL

All	NULL
T-	NULL
and	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
1-glu-tamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
,	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
Logan	NULL
Utah	NULL
)	NULL
.	NULL

Human	NULL
T-cell	NULL
lines	NULL
(	NULL
53	NULL
)	NULL
used	NULL
included	NULL
Jurkat	NULL
(	NULL
CD4+*	NULL
CD8~	NULL
)	NULL
,	NULL
JM	NULL
(	NULL
CD4+*	NULL
CD8a	NULL
«	NULL
*B~	NULL
)	NULL
,	NULL
Molt4	NULL
(	NULL
CD4*	NULL
CD8a*fB~	NULL
)	NULL
,	NULL
and	NULL
HPB.ALL	NULL
(	NULL
CD4+*	NULL
CD8a	NULL
«	NULL
*B*	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus-transformed	NULL
human	NULL
B-cell	NULL
lines	NULL
used	NULL
included	NULL
Raji	NULL
and	NULL
UC	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
non-lymphoid	NULL
cell	NULL
lines	NULL
HeLa	NULL
and	NULL
HepG2	NULL
were	NULL
grown	NULL
in	NULL
minimal	NULL
essential	NULL
medium	NULL
supplemented	NULL
as	NULL
described	NULL
above	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
water-saturated	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitivity	NULL
mapping	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
hypersensitive	NULL
sites	NULL
(	NULL
HS	NULL
)	NULL
were	NULL
mapped	NULL
by	NULL
the	NULL
indirect	NULL
end	NULL
labeling	NULL
technique	NULL
developed	NULL
by	NULL
Wu	NULL
(	NULL
83	NULL
)	NULL
,	NULL
with	NULL
some	NULL
modifications	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
swollen	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
by	NULL
incubation	NULL
in	NULL
hypotonic	NULL
reticulocyte	NULL
standard	NULL
buffer	NULL
,	NULL
lysed	NULL
with	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
immediately	NULL
disrupted	NULL
by	NULL
Dounce	NULL
homogenization	NULL
with	NULL
10	NULL
strokes	NULL
of	NULL
a	NULL
type	NULL
B	NULL
homogenization	NULL
pestle	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
(	NULL
250	NULL
x	NULL
g	NULL
)	NULL
,	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
reticulocyte	NULL
standard	NULL
buffer	NULL
,	NULL
divided	NULL
into	NULL
100-pl	NULL
aliquots	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
pancreatic	NULL
DNase	NULL
I	NULL
(	NULL
0	NULL
,	NULL
0.25	NULL
,	NULL
0.5	NULL
,	NULL
1.0	NULL
,	NULL
2.0	NULL
,	NULL
3.0	NULL
,	NULL
and	NULL
4.0	NULL
pg	NULL
per	NULL
100-pll	NULL
aliquot	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
2	NULL
%	NULL
stop	NULL
solution	NULL
(	NULL
600	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
[	NULL
pH	NULL
8.0	NULL
}	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
and	NULL
500	NULL
ug	NULL
of	NULL
proteinase	NULL
K	NULL
per	NULL
ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
terminate	NULL
the	NULL
reaction	NULL
,	NULL
lyse	NULL
the	NULL
nuclei	NULL
,	NULL
and	NULL
digest	NULL
nuclear	NULL
proteins	NULL
.	NULL

Following	NULL
overnight	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
extensively	NULL
extracted	NULL
with	NULL
phenol-chloroform	NULL
and	NULL
then	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

DNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
digested	NULL
overnight	NULL
with	NULL
HindIII	NULL
,	NULL
electrophore-sed	NULL
on	NULL
a	NULL
0.6	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
NitroPlus	NULL
bybridization	NULL
transfer	NULL
membranes	NULL
(	NULL
Micron	NULL
Separations	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Prehybridized	NULL
blots	NULL
were	NULL
hybridized	NULL
overnight	NULL
with	NULL
a	NULL
random-primed	NULL
,	NULL
*°P-labeled	NULL
752-bp	NULL
HindIII-Pstl	NULL
probe	NULL
encompassing	NULL
the	NULL
first	NULL
intron	NULL
,	NULL
first	NULL
exon	NULL
,	NULL
and	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
«	NULL
gene	NULL
and	NULL
then	NULL
washed	NULL
under	NULL
high-stringency	NULL
conditions	NULL
(	NULL
73	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
film	NULL
.	NULL

Construction	NULL
of	NULL
expression	NULL
vectors	NULL
.	NULL

The	NULL
pTKLux	NULL
plasmid	NULL
Alu-CONTAINING	NULL
T-CELL-SPECIFIC	NULL
CD8	NULL
«	NULL
ENHANCER	NULL
7057	NULL
(	NULL
29	NULL
)	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
firefly	NULL
luciferase-containing	NULL
reporter	NULL
plasmid	NULL
pLuxF47	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
John	NULL
Thompson	NULL
)	NULL
by	NULL
inserting	NULL
a	NULL
polylinker	NULL
(	NULL
annealed	NULL
oligonucleotides	NULL
TCCGCGGCGGCCGCCTCGAGAGTCGACATGCATA-3	NULL
'	NULL
and	NULL
-	NULL
5-GATCTATGCATGTCGACTCTCGAGGCGGCCG	NULL
CCGCGGA-3	NULL
'	NULL
,	NULL
which	NULL
result	NULL
in	NULL
5'-overhanging	NULL
ends	NULL
that	NULL
are	NULL
compatible	NULL
with	NULL
HindIII	NULL
and	NULL
Be/ll	NULL
or	NULL
BamHI	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
BgillI	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
promoter	NULL
(	NULL
52	NULL
)	NULL
.	NULL

A	NULL
1,149-bp	NULL
SphI-XmnI	NULL
fragment	NULL
from	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
«	NULL
gene	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
plasmid	NULL
pgCD8/322	NULL
(	NULL
40	NULL
)	NULL
,	NULL
inserted	NULL
into	NULL
the	NULL
SpAI	NULL
and	NULL
blunted	NULL
XbelI	NULL
sites	NULL
of	NULL
pBLCAT2	NULL
(	NULL
48	NULL
)	NULL
,	NULL
and	NULL
then	NULL
reisolated	NULL
after	NULL
digestion	NULL
with	NULL
HindIII	NULL
and	NULL
BamHI	NULL
.	NULL

This	NULL
HindlIII-BamHI	NULL
fragment	NULL
containing	NULL
the	NULL
1,149-bp	NULL
CD8	NULL
insert	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
plasmids	NULL
pTKCD8U+	NULL
,	NULL
pTKCD8U-	NULL
,	NULL
pTKCD8D+	NULL
,	NULL
and	NULL
pTKCD8D-	NULL
by	NULL
placing	NULL
the	NULL
fragment	NULL
in	NULL
either	NULL
orientation	NULL
(	NULL
+	NULL
and	NULL
-	NULL
)	NULL
both	NULL
upstream	NULL
(	NULL
U	NULL
)	NULL
and	NULL
downstream	NULL
(	NULL
D	NULL
)	NULL
of	NULL
the	NULL
TK	NULL
promoter	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
plasmids	NULL
pTKCD8U+	NULL
and	NULL
pTKCD8U-	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
this	NULL
CD8	NULL
fragment	NULL
with	NULL
the	NULL
same	NULL
polylinker	NULL
(	NULL
see	NULL
above	NULL
)	NULL
into	NULL
pLuxF47	NULL
upstream	NULL
of	NULL
the	NULL
TK	NULL
promoter	NULL
at	NULL
either	NULL
the	NULL
HindIII	NULL
or	NULL
the	NULL
Bgill	NULL
site	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
plasmids	NULL
pTKCD8D+	NULL
and	NULL
pTKCD8D-	NULL
were	NULL
created	NULL
by	NULL
bidirection-ally	NULL
inserting	NULL
this	NULL
fragment	NULL
with	NULL
the	NULL
polylinker	NULL
into	NULL
pLuxF47	NULL
at	NULL
the	NULL
BamHI	NULL
site	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
splice	NULL
sequences	NULL
.	NULL

Generation	NULL
of	NULL
CD8	NULL
enhancer	NULL
deletions	NULL
.	NULL

Nested	NULL
unidirectional	NULL
deletions	NULL
from	NULL
the	NULL
3	NULL
'	NULL
and	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
1,149-bp	NULL
CD8	NULL
intronic	NULL
enhancer	NULL
fragment	NULL
were	NULL
generated	NULL
in	NULL
the	NULL
plasmids	NULL
pTKCD8U+	NULL
and	NULL
pTKCD8U-	NULL
,	NULL
respectively	NULL
(	NULL
Pharmacia	NULL
double-stranded	NULL
nested	NULL
deletion	NULL
kit	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
timed	NULL
digestion	NULL
with	NULL
exonuclease	NULL
III	NULL
and	NULL
subsequent	NULL
digestion	NULL
with	NULL
S1	NULL
nuclease	NULL
,	NULL
pTKCD8U+	NULL
was	NULL
cut	NULL
with	NULL
Xhol	NULL
(	NULL
located	NULL
in	NULL
the	NULL
polylinker	NULL
)	NULL
and	NULL
PstI	NULL
(	NULL
located	NULL
between	NULL
the	NULL
polylinker	NULL
and	NULL
TK	NULL
promoter	NULL
)	NULL
and	NULL
pTKCD8U-	NULL
was	NULL
cut	NULL
with	NULL
Xhol	NULL
and	NULL
NsiI	NULL
(	NULL
both	NULL
located	NULL
in	NULL
the	NULL
polylinker	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
resulting	NULL
deletion-containing	NULL
plasmids	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
exact	NULL
extent	NULL
of	NULL
deletion	NULL
in	NULL
each	NULL
subclone	NULL
.	NULL

The	NULL
nomenclature	NULL
of	NULL
these	NULL
constructs	NULL
reflects	NULL
both	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
deletion	NULL
and	NULL
the	NULL
end	NULL
from	NULL
which	NULL
the	NULL
deletion	NULL
was	NULL
made	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
original	NULL
1,149-bp	NULL
CD8	NULL
fragment	NULL
(	NULL
3	NULL
'	NULL
and	NULL
5	NULL
'	NULL
ends	NULL
correspond	NULL
to	NULL
the	NULL
XmnI	NULL
and	NULL
SphI	NULL
sites	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
p3	NULL
'	NULL
A-280	NULL
is	NULL
a	NULL
plasmid	NULL
in	NULL
which	NULL
the	NULL
CD8	NULL
fragment	NULL
was	NULL
deleted	NULL
280	NULL
bp	NULL
from	NULL
the	NULL
3	NULL
'	NULL
end	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
each	NULL
cell	NULL
line	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Dignam	NULL
(	NULL
14	NULL
)	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
each	NULL
extract	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
,	NULL
except	NULL
that	NULL
7.5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
used	NULL
in	NULL
each	NULL
binding	NULL
reaction	NULL
.	NULL

Previously	NULL
described	NULL
sequence	NULL
from	NULL
the	NULL
human	NULL
CD8a	NULL
intron	NULL
was	NULL
used	NULL
as	NULL
a	NULL
guide	NULL
for	NULL
the	NULL
synthesis	NULL
of	NULL
all	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
each	NULL
protein	NULL
binding	NULL
site	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Double-stranded	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
generated	NULL
by	NULL
first	NULL
annealing	NULL
a	NULL
31-	NULL
to	NULL
33-base	NULL
oligomer	NULL
template	NULL
to	NULL
a	NULL
10-base	NULL
oligomer	NULL
primer	NULL
(	NULL
complementary	NULL
to	NULL
the	NULL
3	NULL
'	NULL
terminal	NULL
10	NULL
bases	NULL
of	NULL
the	NULL
template	NULL
)	NULL
and	NULL
subsequently	NULL
labeled	NULL
with	NULL
[	NULL
a	NULL
«	NULL
-	NULL
``	NULL
°P	NULL
]	NULL
dATP	NULL
and	NULL
[	NULL
«	NULL
-**P	NULL
]	NULL
dCTP	NULL
by	NULL
using	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I.	NULL
Oligomers	NULL
(	NULL
template	NULL
and	NULL
primer	NULL
)	NULL
for	NULL
each	NULL
binding	NULL
site	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
core	NULL
consensus	NULL
binding	NULL
site	NULL
is	NULL
underlined	NULL
and	NULL
lowercase	NULL
letters	NULL
are	NULL
used	NULL
to	NULL
indicate	NULL
the	NULL
mutated	NULL
nucleotides	NULL
.	NULL

For	NULL
cold	NULL
competition	NULL
studies	NULL
,	NULL
unlabeled	NULL
wild-type	NULL
and	NULL
mutant	NULL
templates	NULL
were	NULL
similarly	NULL
produced	NULL
by	NULL
using	NULL
unlabeled	NULL
deoxynu-	NULL
7058	NULL
HAMBOR	NULL
ET	NULL
AL	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

Binding	NULL
site	NULL
oligomers	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

TABLE	NULL
2	NULL
.	NULL

Single-stranded	NULL
oligomers	NULL
used	NULL
as	NULL
primers	NULL
Site	NULL
and	NULL
template	NULL
or	NULL
Sequence	NULL
primer	NULL
LyF-1U	NULL
Wild-type	NULL
template	NULL
5-CCTGCCTCAACCTCCCAAGTAGCTGGGAC-3	NULL
'	NULL
Mutant	NULL
template	NULL
5-CCTGCCTCAACCgcatgcGTAGCTGGGAC-3	NULL
'	NULL
Primer	NULL
3'-ATCGACCCTG-5	NULL
'	NULL
LyF-1D	NULL
Wild-type	NULL
template	NULL
5'-CCCGCCTTGGCCTCCCAAAGTGCTGGGAT-3	NULL
'	NULL
Mutant	NULL
template	NULL
5-CCCGCCTTGGCCaggecctAGTGCTGGGAT-3	NULL
'	NULL
Primer	NULL
3	NULL
-CACGACCCTA-5	NULL
'	NULL
TCF-1	NULL
Wild-type	NULL
template	NULL
5'-CGAATAACTGAGAATAAAGTTCTGCCTTAAG-3	NULL
'	NULL
Mutant	NULL
template	NULL
5'-CGAATAACTGAGcegeggtTTCTGCCTTAAG-3	NULL
'	NULL
Primer	NULL
3'-GACGGAATTC-5	NULL
GATA-3	NULL
Wild-type	NULL
template	NULL
5'-GACGGAGTCTCGCTATCTCGCCCAGGCTGGA-3	NULL
'	NULL
Mutant	NULL
template	NULL
5'-GACGGAGTCTCGaagctTCGCCCAGGCTGGA-3	NULL
'	NULL
Primer	NULL
3'-GGTCCGACCT-5	NULL
'	NULL
ETS	NULL
Wild-type	NULL
template	NULL
5'-GATTTGCTCACATCCTCCTCTCTCCCTGTCA-3	NULL
'	NULL
Mutant	NULL
template	NULL
5'-GATTTGCTCACAcatatgTCTCTCCCTGTCA-3	NULL
'	NULL
Primer	NULL
3'-GAGGGACAGT-5	NULL
'	NULL
cleotides	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
in	NULL
all	NULL
binding	NULL
reactions	NULL
were	NULL
resolved	NULL
by	NULL
using	NULL
nondenaturing	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
.	NULL

A	NULL
653-bp	NULL
minimal	NULL
CD8	NULL
enhancer	NULL
fragment	NULL
was	NULL
isolated	NULL
from	NULL
p3	NULL
'	NULL
A-280	NULL
by	NULL
double	NULL
digestion	NULL
with	NULL
TH1111	NULL
(	NULL
located	NULL
216	NULL
bp	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
)	NULL
and	NULL
Eagl	NULL
(	NULL
located	NULL
between	NULL
the	NULL
280-bp	NULL
3	NULL
'	NULL
deletion	NULL
site	NULL
in	NULL
the	NULL
CD8	NULL
enhancer	NULL
and	NULL
the	NULL
TK	NULL
promoter	NULL
)	NULL
,	NULL
blunted	NULL
by	NULL
a	NULL
Klenow	NULL
fill-in	NULL
reaction	NULL
,	NULL
ligated	NULL
to	NULL
EcoRI	NULL
linkers	NULL
,	NULL
digested	NULL
with	NULL
EcoRI	NULL
,	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pBluescriptSK+	NULL
(	NULL
Strata-gene	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
(	NULL
pBSCD8min	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
minimal	NULL
CD8a	NULL
«	NULL
enhancer	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Kunkel	NULL
(	NULL
42	NULL
)	NULL
(	NULL
Bio-Rad	NULL
Muta-gene	NULL
Kit	NULL
)	NULL
.	NULL

Single-stranded	NULL
oligomers	NULL
containing	NULL
mutations	NULL
in	NULL
individual	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
identical	NULL
to	NULL
the	NULL
mutant	NULL
templates	NULL
used	NULL
to	NULL
generate	NULL
probes	NULL
for	NULL
EMSA	NULL
(	NULL
see	NULL
method	NULL
for	NULL
EMSA	NULL
described	NULL
above	NULL
)	NULL
,	NULL
were	NULL
used	NULL
as	NULL
primers	NULL
for	NULL
the	NULL
mutagenesis	NULL
reactions	NULL
.	NULL

In	NULL
order	NULL
to	NULL
mutate	NULL
the	NULL
CRE	NULL
and	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
protein	NULL
binding	NULL
sites	NULL
,	NULL
the	NULL
single-stranded	NULL
oligomers	NULL
listed	NULL
in	NULL
Table	NULL
2	NULL
were	NULL
used	NULL
as	NULL
primers	NULL
.	NULL

The	NULL
nucleotides	NULL
in	NULL
lowercase	NULL
letters	NULL
represent	NULL
the	NULL
changes	NULL
introduced	NULL
into	NULL
the	NULL
wild-type	NULL
CD8	NULL
sequence	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
.	NULL

The	NULL
wild-type	NULL
sequence	NULL
,	NULL
shown	NULL
merely	NULL
for	NULL
comparison	NULL
to	NULL
the	NULL
consensus	NULL
sequences	NULL
for	NULL
each	NULL
binding	NULL
site	NULL
,	NULL
was	NULL
not	NULL
used	NULL
in	NULL
these	NULL
mutagenesis	NULL
reactions	NULL
.	NULL

Both	NULL
single	NULL
and	NULL
double	NULL
mutants	NULL
for	NULL
each	NULL
site	NULL
were	NULL
produced	NULL
.	NULL

All	NULL
mutants	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
wild-type	NULL
minimal	NULL
CD8	NULL
enhancer	NULL
,	NULL
were	NULL
sequenced	NULL
,	NULL
isolated	NULL
from	NULL
pBSCD8min	NULL
by	NULL
digestion	NULL
Site	NULL
and	NULL
primer	NULL
Sequence	NULL
CRE	NULL
Consensus	NULL
motif	NULL
TGACGTCA	NULL
Wild-type	NULL
5'-AGAGTGCAGACATGACGTCATGATGAATTAG-5	NULL
'	NULL
Mutant	NULL
5'-AGAGTGCAGACActecgagCATGATGAATTAG-3	NULL
'	NULL
bHLH	NULL
Consensus	NULL
motif	NULL
CANNTG	NULL
Wild-type	NULL
5'-GATCTCCTGACCACGTGATCCGCCCGCCTTG-3	NULL
'	NULL
Mutant	NULL
5'-GATCTCCTGACgeggecegeCCGCCCGCCTTG-3	NULL
'	NULL
with	NULL
HindIII	NULL
and	NULL
BamHI	NULL
,	NULL
and	NULL
then	NULL
subcloned	NULL
into	NULL
pTKLux	NULL
between	NULL
the	NULL
HindIII	NULL
and	NULL
Bg/ll	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
TK	NULL
promoter	NULL
.	NULL

Of	NULL
these	NULL
constructs	NULL
,	NULL
the	NULL
plasmid	NULL
designated	NULL
pTKCD8min	NULL
contains	NULL
the	NULL
wild-type	NULL
minimal	NULL
CD8	NULL
enhancer	NULL
.	NULL

Single	NULL
and	NULL
double	NULL
mutants	NULL
for	NULL
each	NULL
site	NULL
are	NULL
designated	NULL
by	NULL
pm	NULL
followed	NULL
by	NULL
the	NULL
site	NULL
name	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
plasmid	NULL
in	NULL
which	NULL
the	NULL
Ets-1	NULL
site	NULL
was	NULL
mutated	NULL
is	NULL
designated	NULL
pmEts-1	NULL
,	NULL
whereas	NULL
the	NULL
plasmid	NULL
containing	NULL
mutations	NULL
in	NULL
both	NULL
the	NULL
GATA-3	NULL
and	NULL
LyF-lu	NULL
sites	NULL
is	NULL
designated	NULL
pmGATA-3/LyF-lu	NULL
.	NULL

Transfection	NULL
of	NULL
DNA	NULL
into	NULL
tissue	NULL
culture	NULL
cells	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
cotransfected	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
each	NULL
luciferase	NULL
reporter	NULL
construct	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
the	NULL
reference	NULL
plasmid	NULL
pCMVB-gal	NULL
(	NULL
49	NULL
)	NULL
used	NULL
to	NULL
determine	NULL
transfection	NULL
efficiency	NULL
.	NULL

In	NULL
each	NULL
transfection	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
800	NULL
pl	NULL
of	NULL
serum-free	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
for	NULL
JM	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
and	NULL
minimal	NULL
essential	NULL
medium	NULL
for	NULL
HeLa	NULL
cells	NULL
)	NULL
were	NULL
electroporated	NULL
by	NULL
using	NULL
a	NULL
Gene	NULL
Pulsar	NULL
(	NULL
Bio-Rad	NULL
)	NULL
set	NULL
at	NULL
960	NULL
uF	NULL
and	NULL
either	NULL
250	NULL
V	NULL
for	NULL
Jurkat	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
or	NULL
270	NULL
V	NULL
for	NULL
JM	NULL
cells	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
complete	NULL
medium	NULL
for	NULL
40	NULL
to	NULL
48	NULL
h	NULL
,	NULL
harvested	NULL
,	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Cell	NULL
pellets	NULL
were	NULL
lysed	NULL
(	NULL
luciferase	NULL
assay	NULL
system	NULL
;	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
and	NULL
extracts	NULL
quantitated	NULL
for	NULL
protein	NULL
concentration	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Luciferase	NULL
and	NULL
B-galactosidase	NULL
assays	NULL
.	NULL

Cell	NULL
lysates	NULL
containing	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
protein	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
(	NULL
luciferase	NULL
assay	NULL
system	NULL
;	NULL
Promega	NULL
)	NULL
,	NULL
by	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
described	NULL
by	NULL
deWet	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
16	NULL
)	NULL
.	NULL

For	NULL
each	NULL
transfection	NULL
,	NULL
a	NULL
standardized	NULL
luciferase	NULL
value	NULL
was	NULL
derived	NULL
(	NULL
luciferase	NULL
activity/B-galactosidase	NULL
activity	NULL
)	NULL
in	NULL
order	NULL
to	NULL
adjust	NULL
for	NULL
variability	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

Standardized	NULL
values	NULL
for	NULL
enhancer-containing	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
were	NULL
subsequently	NULL
normalized	NULL
to	NULL
those	NULL
obtained	NULL
for	NULL
either	NULL
pTKLux	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
or	NULL
pTKCD8min	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
Student	NULL
¢	NULL
test	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
was	NULL
used	NULL
to	NULL
address	NULL
the	NULL
statistical	NULL
significance	NULL
of	NULL
these	NULL
results	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
accession	NULL
number	NULL
.	NULL

The	NULL
GenBank	NULL
accession	NULL
number	NULL
M27161	NULL
has	NULL
been	NULL
assigned	NULL
to	NULL
the	NULL
human	NULL
CD8a	NULL
intron	NULL
sequence	NULL
.	NULL

RESULTS	NULL
Mapping	NULL
of	NULL
DNase	NULL
I	NULL
HS	NULL
.	NULL

The	NULL
first	NULL
step	NULL
towards	NULL
an	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
CD8	NULL
gene	NULL
regulation	NULL
requires	NULL
the	NULL
identification	NULL
of	NULL
cis-acting	NULL
DNA	NULL
regulatory	NULL
elements	NULL
.	NULL

In	NULL
many	NULL
developmentally	NULL
regulated	NULL
and	NULL
tissue-specific	NULL
genes	NULL
such	NULL
as	NULL
CD8	NULL
,	NULL
DNase	NULL
I	NULL
HS	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
regions	NULL
active	NULL
in	NULL
transcriptional	NULL
control	NULL
,	NULL
and	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
their	NULL
appearance	NULL
has	NULL
been	NULL
correlated	NULL
with	NULL
both	NULL
gene	NULL
expression	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
trans-acting	NULL
regulatory	NULL
factors	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
26	NULL
,	NULL
27	NULL
,	NULL
30	NULL
,	NULL
33	NULL
,	NULL
69	NULL
,	NULL
82	NULL
,	NULL
83	NULL
)	NULL
.	NULL

To	NULL
locate	NULL
regions	NULL
potentially	NULL
accessible	NULL
to	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
the	NULL
chromatin	NULL
structure	NULL
surrounding	NULL
the	NULL
human	NULL
CD8a	NULL
gene	NULL
was	NULL
mapped	NULL
for	NULL
sites	NULL
that	NULL
are	NULL
hypersensitive	NULL
to	NULL
digestion	NULL
with	NULL
DNase	NULL
I	NULL
.	NULL

In	NULL
order	NULL
to	NULL
identify	NULL
tissue-specific	NULL
DNase	NULL
I	NULL
HS	NULL
,	NULL
two	NULL
human	NULL
leukemic	NULL
T-cell	NULL
lines	NULL
,	NULL
HPB.ALL	NULL
(	NULL
CD8a	NULL
«	NULL
*B*	NULL
CD4*	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
CD87	NULL
CD4*	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
control	NULL
non-T	NULL
-cell	NULL
lines	NULL
,	NULL
Raji	NULL
(	NULL
an	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B-cell	NULL
line	NULL
)	NULL
and	NULL
HeLa	NULL
(	NULL
a	NULL
fibroblast	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
were	NULL
analyzed	NULL
.	NULL

DNA	NULL
was	NULL
prepared	NULL
from	NULL
DNase	NULL
I-digested	NULL
nuclei	NULL
,	NULL
restricted	NULL
with	NULL
HindIII	NULL
,	NULL
electrophoresed	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
762-bp	NULL
HindIII-PstI	NULL
5°	NULL
probe	NULL
which	NULL
detects	NULL
a	NULL
14-kb	NULL
genomic	NULL
band	NULL
in	NULL
HindIII-digested	NULL
DNA	NULL
from	NULL
untreated	NULL
nuclei	NULL
.	NULL

By	NULL
using	NULL
this	NULL
approach	NULL
,	NULL
four	NULL
subfragments	NULL
representing	NULL
distinct	NULL
DNase	NULL
I	NULL
HS	NULL
were	NULL
identified	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

HS1	NULL
,	NULL
found	NULL
in	NULL
both	NULL
T-and	NULL
non-T-cell	NULL
lines	NULL
,	NULL
mapped	NULL
to	NULL
the	NULL
intron	NULL
between	NULL
exons	NULL
IV	NULL
and	NULL
V	NULL
,	NULL
while	NULL
HS2	NULL
and	NULL
HS3	NULL
,	NULL
found	NULL
in	NULL
the	NULL
last	NULL
intron	NULL
,	NULL
appear	NULL
exclusively	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
intensity	NULL
and	NULL
broadness	NULL
of	NULL
HS3	NULL
,	NULL
the	NULL
most	NULL
predominant	NULL
T-cell-specific	NULL
site	NULL
identified	NULL
,	NULL
may	NULL
reflect	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
HS	NULL
sites	NULL
in	NULL
this	NULL
region	NULL
.	NULL

HS4	NULL
,	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
last	NULL
exon	NULL
,	NULL
is	NULL
also	NULL
very	NULL
prominent	NULL
in	NULL
the	NULL
two	NULL
T-cell	NULL
lines	NULL
,	NULL
less	NULL
prominent	NULL
in	NULL
the	NULL
B-cell	NULL
line	NULL
,	NULL
and	NULL
absent	NULL
in	NULL
the	NULL
fibroblast	NULL
cell	NULL
line	NULL
.	NULL

A	NULL
computer-assisted	NULL
search	NULL
of	NULL
the	NULL
known	NULL
human	NULL
CDSa	NULL
genomic	NULL
sequence	NULL
(	NULL
57	NULL
)	NULL
for	NULL
potential	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
(	NULL
17	NULL
)	NULL
revealed	NULL
a	NULL
striking	NULL
cluster	NULL
of	NULL
consensus	NULL
motifs	NULL
for	NULL
DNA-binding	NULL
proteins	NULL
near	NULL
the	NULL
location	NULL
of	NULL
HS2	NULL
and	NULL
HS3	NULL
within	NULL
the	NULL
last	NULL
intron	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
motifs	NULL
are	NULL
homologous	NULL
to	NULL
those	NULL
found	NULL
in	NULL
the	NULL
tissue-specific	NULL
regulatory	NULL
regions	NULL
of	NULL
other	NULL
T-cell-specific	NULL
genes	NULL
(	NULL
20	NULL
,	NULL
23	NULL
,	NULL
31	NULL
,	NULL
38	NULL
,	NULL
41	NULL
,	NULL
44	NULL
,	NULL
45	NULL
,	NULL
50	NULL
,	NULL
51	NULL
,	NULL
64-66	NULL
,	NULL
74	NULL
,	NULL
76	NULL
,	NULL
81	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
C	NULL
,	NULL
putative	NULL
DNA-binding	NULL
sites	NULL
for	NULL
GATA-3	NULL
(	NULL
37	NULL
)	NULL
,	NULL
TCF-1	NULL
(	NULL
45	NULL
,	NULL
79	NULL
)	NULL
,	NULL
Ets-1	NULL
(	NULL
80	NULL
)	NULL
,	NULL
and	NULL
LyF-1	NULL
(	NULL
47	NULL
)	NULL
(	NULL
two	NULL
sites	NULL
)	NULL
were	NULL
identified	NULL
within	NULL
a	NULL
700-bp	NULL
region	NULL
of	NULL
this	NULL
last	NULL
intron	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
for	NULL
consensus	NULL
sequences	NULL
for	NULL
each	NULL
motif	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
potential	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
(	NULL
11	NULL
,	NULL
21	NULL
,	NULL
39	NULL
,	NULL
43	NULL
,	NULL
65	NULL
)	NULL
and	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
bHLH	NULL
protein	NULL
(	NULL
28	NULL
,	NULL
54	NULL
,	NULL
55	NULL
,	NULL
61	NULL
)	NULL
were	NULL
found	NULL
within	NULL
this	NULL
region	NULL
(	NULL
see	NULL
Table	NULL
2	NULL
and	NULL
Fig	NULL
.	NULL

5	NULL
to	NULL
8	NULL
for	NULL
consensus	NULL
sequences	NULL
for	NULL
each	NULL
motif	NULL
)	NULL
.	NULL

We	NULL
also	NULL
found	NULL
a	NULL
full-length	NULL
Alu	NULL
repeat	NULL
next	NULL
to	NULL
an	NULL
inverted	NULL
half-4/u	NULL
repeat	NULL
.	NULL

The	NULL
full-length	NULL
Alu	NULL
sequence	NULL
contained	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
GATA-3	NULL
,	NULL
LyF-1	NULL
,	NULL
and	NULL
bHLH	NULL
proteins	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
intronic	NULL
region	NULL
containing	NULL
the	NULL
putative	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
AZu	NULL
repeats	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
.	NULL

A	NULL
T-cell-specific	NULL
enhancer	NULL
resides	NULL
in	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
human	NULL
CDS8	NULL
«	NULL
gene	NULL
.	NULL

The	NULL
correlation	NULL
between	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
strong	NULL
T-cell-specific	NULL
HS	NULL
and	NULL
the	NULL
location	NULL
of	NULL
several	NULL
consensus	NULL
motifs	NULL
suggested	NULL
that	NULL
a	NULL
tissue-specific	NULL
regulatory	NULL
region	NULL
resides	NULL
within	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
CD8a	NULL
«	NULL
gene	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
a	NULL
transcriptional	NULL
enhancer	NULL
element	NULL
was	NULL
present	NULL
within	NULL
the	NULL
last	NULL
intron	NULL
,	NULL
a	NULL
1,149-bp	NULL
fragment	NULL
generated	NULL
by	NULL
SphI-XmnI	NULL
double	NULL
digestion	NULL
was	NULL
subcloned	NULL
into	NULL
an	NULL
expression	NULL
vector	NULL
(	NULL
pTKLux	NULL
)	NULL
in	NULL
which	NULL
the	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
is	NULL
driven	NULL
by	NULL
a	NULL
minimal	NULL
heterologous	NULL
promoter	NULL
element	NULL
from	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
TK	NULL
gene	NULL
.	NULL

Recombi-nant	NULL
plasmids	NULL
with	NULL
this	NULL
CDS8a	NULL
«	NULL
intronic	NULL
fragment	NULL
inserted	NULL
in	NULL
both	NULL
orientations	NULL
(	NULL
+	NULL
and	NULL
-	NULL
)	NULL
,	NULL
both	NULL
upstream	NULL
(	NULL
pTKCD8U-and	NULL
pTKCD8U+	NULL
)	NULL
and	NULL
downstream	NULL
(	NULL
pTKCD8D-	NULL
and	NULL
pTKCD8D+	NULL
)	NULL
of	NULL
the	NULL
TK	NULL
promoter	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
pTKLux	NULL
parent	NULL
plasmid	NULL
lacking	NULL
this	NULL
CD8	NULL
fragment	NULL
,	NULL
were	NULL
independently	NULL
transfected	NULL
into	NULL
a	NULL
panel	NULL
of	NULL
T-	NULL
and	NULL
non-T-cell	NULL
lines	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
40	NULL
to	NULL
48	NULL
h	NULL
later	NULL
.	NULL

This	NULL
CD8a	NULL
intronic	NULL
fragment	NULL
enhanced	NULL
expression	NULL
by	NULL
the	NULL
TK	NULL
promoter	NULL
by	NULL
15-	NULL
to	NULL
30-fold	NULL
in	NULL
the	NULL
T-cell	NULL
lines	NULL
Jurkat	NULL
(	NULL
CD87	NULL
CD4*	NULL
)	NULL
and	NULL
Alu-CONTAINING	NULL
T-CELL-SPECIFIC	NULL
CD8	NULL
«	NULL
ENHANCER	NULL
7059	NULL
JM	NULL
(	NULL
CD8a*B~	NULL
CD4*	NULL
)	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
expression	NULL
in	NULL
two	NULL
non-T-cell	NULL
lines	NULL
,	NULL
Raji	NULL
and	NULL
HeLa	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
results	NULL
also	NULL
demonstrate	NULL
that	NULL
the	NULL
last	NULL
intron	NULL
contains	NULL
an	NULL
enhancer	NULL
element	NULL
that	NULL
functions	NULL
in	NULL
an	NULL
orientation-	NULL
and	NULL
position-independent	NULL
fashion	NULL
and	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
directing	NULL
T-cell-specific	NULL
expression	NULL
of	NULL
the	NULL
CD8a	NULL
gene	NULL
.	NULL

Delineation	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
element	NULL
.	NULL

In	NULL
order	NULL
to	NULL
define	NULL
the	NULL
boundaries	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
element	NULL
,	NULL
deletions	NULL
from	NULL
the	NULL
3	NULL
'	NULL
and	NULL
5'°	NULL
ends	NULL
of	NULL
the	NULL
1,149-bp	NULL
CD8	NULL
intronic	NULL
enhancer	NULL
fragment	NULL
were	NULL
generated	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
for	NULL
location	NULL
of	NULL
each	NULL
deletion	NULL
)	NULL
and	NULL
tested	NULL
for	NULL
enhancer	NULL
activity	NULL
by	NULL
using	NULL
the	NULL
reporter-based	NULL
transient	NULL
expression	NULL
system	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
C	NULL
,	NULL
these	NULL
constructs	NULL
produced	NULL
similar	NULL
results	NULL
when	NULL
tested	NULL
in	NULL
two	NULL
T-cell	NULL
lines	NULL
,	NULL
JM	NULL
and	NULL
Jurkat	NULL
,	NULL
but	NULL
were	NULL
not	NULL
active	NULL
in	NULL
non-T-cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
up	NULL
to	NULL
280	NULL
bp	NULL
from	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
this	NULL
fragment	NULL
(	NULL
deletion	NULL
constructs	NULL
p3	NULL
'	NULL
A-95	NULL
,	NULL
p3	NULL
'	NULL
A-219	NULL
,	NULL
p3	NULL
'	NULL
A-250	NULL
,	NULL
and	NULL
p3	NULL
'	NULL
A-280	NULL
)	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
enhancer	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
further	NULL
deletion	NULL
of	NULL
52	NULL
bp	NULL
(	NULL
p3	NULL
'	NULL
A-332	NULL
)	NULL
,	NULL
including	NULL
DNA	NULL
sequences	NULL
containing	NULL
the	NULL
putative	NULL
Ets	NULL
binding	NULL
site	NULL
,	NULL
dramatically	NULL
reduced	NULL
enhancer	NULL
activity	NULL
.	NULL

Truncation	NULL
of	NULL
an	NULL
additional	NULL
178	NULL
bp	NULL
(	NULL
p3	NULL
'	NULL
A-510	NULL
)	NULL
resulted	NULL
in	NULL
total	NULL
loss	NULL
of	NULL
activity	NULL
.	NULL

The	NULL
site	NULL
of	NULL
the	NULL
280-bp	NULL
deletion	NULL
in	NULL
the	NULL
plasmid	NULL
p3'A280	NULL
therefore	NULL
represents	NULL
the	NULL
3	NULL
'	NULL
boundary	NULL
of	NULL
this	NULL
T-cell-specific	NULL
enhancer	NULL
.	NULL

Analysis	NULL
of	NULL
deletion	NULL
constructs	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
1,149-bp	NULL
enhancer	NULL
fragment	NULL
revealed	NULL
a	NULL
more	NULL
complicated	NULL
set	NULL
of	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Whereas	NULL
deletion	NULL
of	NULL
18	NULL
bp	NULL
(	NULL
pS	NULL
'	NULL
A-18	NULL
)	NULL
was	NULL
inconsequential	NULL
,	NULL
loss	NULL
of	NULL
203	NULL
or	NULL
204	NULL
bp	NULL
(	NULL
pS	NULL
and	NULL
pS	NULL
'	NULL
A-204	NULL
,	NULL
respectively	NULL
)	NULL
encompassing	NULL
the	NULL
entire	NULL
half-4/u	NULL
repeat	NULL
significantly	NULL
augmented	NULL
the	NULL
strength	NULL
of	NULL
this	NULL
enhancer	NULL
by	NULL
an	NULL
additional	NULL
fivefold	NULL
.	NULL

Although	NULL
this	NULL
result	NULL
suggests	NULL
that	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
is	NULL
present	NULL
in	NULL
this	NULL
half-4/u	NULL
repeat	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
1,149-bp	NULL
fragment	NULL
,	NULL
this	NULL
sequence	NULL
did	NULL
not	NULL
have	NULL
any	NULL
effect	NULL
when	NULL
added	NULL
back	NULL
to	NULL
p5	NULL
'	NULL
A-203	NULL
downstream	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
polyadenylation/splice	NULL
signal	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
position	NULL
of	NULL
this	NULL
region	NULL
is	NULL
critical	NULL
for	NULL
its	NULL
negative	NULL
effect	NULL
on	NULL
the	NULL
adjacent	NULL
enhancer	NULL
.	NULL

The	NULL
deletion	NULL
construct	NULL
p5	NULL
'	NULL
A-290	NULL
,	NULL
which	NULL
lacks	NULL
290	NULL
bp	NULL
of	NULL
sequence	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
,	NULL
including	NULL
the	NULL
putative	NULL
GATA-3	NULL
binding	NULL
site	NULL
,	NULL
demonstrated	NULL
less	NULL
activity	NULL
than	NULL
either	NULL
pS5	NULL
'	NULL
A-203	NULL
or	NULL
p5	NULL
'	NULL
A-204	NULL
but	NULL
functioned	NULL
as	NULL
well	NULL
as	NULL
pTKCD8U-	NULL
(	NULL
containing	NULL
the	NULL
full-length	NULL
1,149-bp	NULL
fragment	NULL
)	NULL
.	NULL

Further	NULL
truncation	NULL
of	NULL
an	NULL
additional	NULL
99	NULL
bp	NULL
(	NULL
pS	NULL
A-389	NULL
)	NULL
including	NULL
the	NULL
putative	NULL
upstream	NULL
LyF-1	NULL
site	NULL
(	NULL
LyF-1u	NULL
)	NULL
resulted	NULL
in	NULL
almost	NULL
complete	NULL
loss	NULL
of	NULL
enhancer	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
the	NULL
5	NULL
'	NULL
border	NULL
of	NULL
the	NULL
intronic	NULL
region	NULL
possessing	NULL
maximal	NULL
enhancer	NULL
activity	NULL
is	NULL
delimited	NULL
at	NULL
the	NULL
203-or	NULL
204-bp	NULL
deletion	NULL
site	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
minimal	NULL
T-cell-specific	NULL
enhancer	NULL
fragment	NULL
with	NULL
maximal	NULL
activity	NULL
was	NULL
further	NULL
localized	NULL
to	NULL
a	NULL
653-bp	NULL
fragment	NULL
defined	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
by	NULL
the	NULL
280-bp	NULL
deletion	NULL
site	NULL
and	NULL
the	NULL
5	NULL
end	NULL
by	NULL
a	NULL
THh1111	NULL
site	NULL
representing	NULL
a	NULL
deletion	NULL
of	NULL
216	NULL
bp	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
for	NULL
location	NULL
of	NULL
deletion	NULL
sites	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
containing	NULL
this	NULL
653-bp	NULL
fragment	NULL
,	NULL
pTKCD8min	NULL
,	NULL
was	NULL
as	NULL
active	NULL
in	NULL
T-cell	NULL
lines	NULL
as	NULL
either	NULL
pS	NULL
A-203	NULL
or	NULL
p5	NULL
'	NULL
A-204	NULL
in	NULL
the	NULL
transient	NULL
transfection	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
minimal	NULL
enhancer	NULL
was	NULL
not	NULL
active	NULL
in	NULL
the	NULL
B-lymphoblastoid	NULL
line	NULL
Raji	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
653-bp	NULL
fragment	NULL
,	NULL
containing	NULL
the	NULL
putative	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
for	NULL
GATA-3	NULL
,	NULL
LyF-1	NULL
(	NULL
two	NULL
sites	NULL
)	NULL
,	NULL
bHLH	NULL
,	NULL
TCF-1	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
Ets-1	NULL
,	NULL
represents	NULL
the	NULL
core	NULL
CD8a	NULL
enhancer	NULL
which	NULL
possesses	NULL
T-cell-specific	NULL
activity	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
minimal	NULL
CD8	NULL
enhancer	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
each	NULL
of	NULL
the	NULL
putative	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
CD8a	NULL
«	NULL
enhancer	NULL
,	NULL
a	NULL
series	NULL
of	NULL
site-directed	NULL
mutants	NULL
were	NULL
generated	NULL
and	NULL
tested	NULL
for	NULL
their	NULL
effects	NULL
on	NULL
enhancer	NULL
activity	NULL
in	NULL
both	NULL
JM	NULL
and	NULL
Jurkat	NULL
T	NULL
7060	NULL
HAMBOR	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

A	NULL
HS1	NULL
ns2	NULL
HS3	NULL
HS4	NULL
_1	NULL
Kb	NULL
_	NULL
H	NULL
P	NULL
S	NULL
X	NULL
H	NULL
Jt	NULL
_|	NULL
|	NULL
|	NULL
L_	NULL
Exons	NULL
:	NULL
I	NULL
II	NULL
IIIV	NULL
V	NULL
VI	NULL
100	NULL
bp	NULL
LyF-1	NULL
LyF-1	NULL
CRE	NULL
lst	NULL
GATA-3	NULL
bHLH	NULL
TCF-1	NULL
Ets-1	NULL
gor	NULL
sou	NULL
I	NULL
}	NULL
--	NULL
half	NULL
Alu	NULL
full-length	NULL
Alu	NULL
B.	NULL
HeLa	NULL
Raji	NULL
HPB.ALL	NULL
Jurkat	NULL
e	NULL
cca	NULL
~-	NULL
m	NULL
<	NULL
-	NULL
HS4	NULL
j	NULL
*-	NULL
HS3	NULL
--	NULL
HS2	NULL
J	NULL
<	NULL
HS1	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitivity	NULL
mapping	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
gene	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Partial	NULL
restriction	NULL
map	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
gene	NULL
with	NULL
the	NULL
six	NULL
exons	NULL
denoted	NULL
by	NULL
roman	NULL
numerals	NULL
and	NULL
represented	NULL
by	NULL
solid	NULL
boxes	NULL
.	NULL

The	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
are	NULL
represented	NULL
by	NULL
open	NULL
boxes	NULL
.	NULL

DNase	NULL
I	NULL
HS	NULL
(	NULL
HS1	NULL
to	NULL
HS4	NULL
)	NULL
are	NULL
marked	NULL
with	NULL
vertical	NULL
arrows	NULL
;	NULL
the	NULL
more	NULL
prominent	NULL
HS	NULL
are	NULL
depicted	NULL
by	NULL
the	NULL
thicker	NULL
arrows	NULL
.	NULL

The	NULL
thin	NULL
vertical	NULL
bars	NULL
designated	NULL
H	NULL
,	NULL
P	NULL
,	NULL
S	NULL
,	NULL
and	NULL
X	NULL
represent	NULL
sites	NULL
for	NULL
the	NULL
restriction	NULL
enzymes	NULL
HindlIH	NULL
,	NULL
Psfl	NULL
,	NULL
SphI	NULL
,	NULL
and	NULL
Xmnl	NULL
,	NULL
respectively	NULL
.	NULL

Within	NULL
the	NULL
1,149-bp	NULL
enhancer	NULL
fragment	NULL
,	NULL
isolated	NULL
by	NULL
SphI	NULL
and	NULL
XmnI	NULL
digestion	NULL
,	NULL
the	NULL
locations	NULL
of	NULL
the	NULL
protein	NULL
binding	NULL
site	NULL
consensus	NULL
motifs	NULL
for	NULL
GATA-3	NULL
,	NULL
LyF-1	NULL
,	NULL
TCF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
bHLH	NULL
proteins	NULL
are	NULL
depicted	NULL
.	NULL

For	NULL
the	NULL
exact	NULL
sequence	NULL
of	NULL
each	NULL
consensus	NULL
motif	NULL
,	NULL
see	NULL
Tables	NULL
1	NULL
and	NULL
2	NULL
or	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
the	NULL
full-length	NULL
and	NULL
half-4/u	NULL
repeats	NULL
are	NULL
shown	NULL
beneath	NULL
the	NULL
1,149-bp	NULL
SphI-BamHI	NULL
fragment	NULL
.	NULL

Size	NULL
markers	NULL
(	NULL
1	NULL
kb	NULL
and	NULL
100	NULL
bp	NULL
)	NULL
for	NULL
the	NULL
14-kb	NULL
HindIII	NULL
genomic	NULL
fragment	NULL
and	NULL
the	NULL
1,149-bp	NULL
SphI-XmnI	NULL
enhancer	NULL
fragment	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Southern	NULL
analysis	NULL
demonstrating	NULL
the	NULL
position	NULL
,	NULL
strength	NULL
,	NULL
and	NULL
tissue	NULL
distribution	NULL
of	NULL
HS1	NULL
to	NULL
HS4	NULL
.	NULL

As	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
nuclei	NULL
from	NULL
the	NULL
human	NULL
cell	NULL
lines	NULL
HeLa	NULL
(	NULL
nonlymphoid	NULL
)	NULL
,	NULL
Raji	NULL
(	NULL
B	NULL
cell	NULL
)	NULL
,	NULL
HPB.ALL	NULL
(	NULL
CD4*	NULL
CD8	NULL
«	NULL
*B*	NULL
)	NULL
,	NULL
and	NULL
Jurkat	NULL
(	NULL
CD4*	NULL
CD8~	NULL
)	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
indicated	NULL
by	NULL
the	NULL
wedges	NULL
,	NULL
representing	NULL
0.25	NULL
,	NULL
0.5	NULL
,	NULL
1.0	NULL
,	NULL
2.0	NULL
,	NULL
3.0	NULL
,	NULL
and	NULL
4.0	NULL
g/100	NULL
pl	NULL
)	NULL
prior	NULL
to	NULL
isolation	NULL
of	NULL
genomic	NULL
DNA	NULL
,	NULL
restriction	NULL
with	NULL
HindIII	NULL
,	NULL
and	NULL
Southern	NULL
analysis	NULL
with	NULL
a	NULL
752-bp	NULL
*°P-labeled	NULL
probe	NULL
isolated	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
gene	NULL
by	NULL
HindIII	NULL
and	NULL
Psfl	NULL
digestion	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
the	NULL
9.5-	NULL
,	NULL
5.0-	NULL
,	NULL
4.0-	NULL
,	NULL
and	NULL
2.5-kb	NULL
fragments	NULL
corresponding	NULL
to	NULL
HS1	NULL
to	NULL
HS4	NULL
,	NULL
respectively	NULL
,	NULL
are	NULL
indicated	NULL
along	NULL
the	NULL
right	NULL
side	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
CD8	NULL
intronic	NULL
enhancer	NULL
.	NULL

This	NULL
sequence	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
published	NULL
by	NULL
Nakayama	NULL
et	NULL
al	NULL
.	NULL

(	NULL
56	NULL
)	NULL
except	NULL
for	NULL
the	NULL
deletion	NULL
of	NULL
a	NULL
24-bp	NULL
sequence	NULL
(	NULL
5'-CAGCTGGGACTACAGGCACCCGCC-3	NULL
'	NULL
,	NULL
corresponding	NULL
to	NULL
positions	NULL
345	NULL
to	NULL
367	NULL
)	NULL
that	NULL
was	NULL
tandemly	NULL
duplicated	NULL
in	NULL
their	NULL
sequence	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
SpAI	NULL
,	NULL
THh1111	NULL
,	NULL
and	NULL
A-280	NULL
sites	NULL
are	NULL
shown	NULL
with	NULL
arrowheads	NULL
.	NULL

Sequences	NULL
encoded	NULL
by	NULL
an	NULL
Alu	NULL
repeat	NULL
are	NULL
underlined	NULL
,	NULL
and	NULL
sequences	NULL
composing	NULL
a	NULL
protein	NULL
binding	NULL
site	NULL
are	NULL
overlined	NULL
and	NULL
labeled	NULL
.	NULL

Position	NULL
1	NULL
corresponds	NULL
to	NULL
the	NULL
first	NULL
nucleotide	NULL
of	NULL
the	NULL
half-4lu	NULL
repeat	NULL
.	NULL

cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

While	NULL
mutation	NULL
of	NULL
the	NULL
putative	NULL
core	NULL
sequences	NULL
in	NULL
individual	NULL
binding	NULL
sites	NULL
for	NULL
GATA-3	NULL
,	NULL
LyF-1u	NULL
(	NULL
upstream	NULL
site	NULL
)	NULL
,	NULL
LyF-1d	NULL
(	NULL
downstream	NULL
site	NULL
)	NULL
,	NULL
bHLH	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
TCF-1	NULL
resulted	NULL
in	NULL
incomplete	NULL
but	NULL
significant	NULL
(	NULL
12	NULL
to	NULL
60	NULL
%	NULL
)	NULL
reductions	NULL
in	NULL
enhancer	NULL
activity	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
core	NULL
sequence	NULL
for	NULL
the	NULL
putative	NULL
Ets	NULL
binding	NULL
site	NULL
was	NULL
most	NULL
deleterious	NULL
to	NULL
enhancer	NULL
function	NULL
.	NULL

Analysis	NULL
of	NULL
these	NULL
single-site	NULL
mutants	NULL
indicated	NULL
that	NULL
the	NULL
function	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
is	NULL
most	NULL
dramatically	NULL
affected	NULL
by	NULL
mutation	NULL
of	NULL
either	NULL
the	NULL
putative	NULL
GATA-3	NULL
or	NULL
Ets-1	NULL
DNA	NULL
motifs	NULL
which	NULL
are	NULL
located	NULL
at	NULL
either	NULL
end	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
fragment	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
that	NULL
of	NULL
the	NULL
deletion	NULL
analysis	NULL
,	NULL
which	NULL
demonstrated	NULL
a	NULL
dramatic	NULL
decline	NULL
in	NULL
enhancer	NULL
activity	NULL
upon	NULL
removal	NULL
of	NULL
sequences	NULL
containing	NULL
either	NULL
the	NULL
putative	NULL
GATA-3	NULL
or	NULL
Ets-1	NULL
binding	NULL
sites	NULL
.	NULL

Since	NULL
other	NULL
enhancer	NULL
regions	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
functionally	NULL
redundant	NULL
cis-acting	NULL
elements	NULL
,	NULL
the	NULL
contribution	NULL
of	NULL
each	NULL
binding	NULL
site	NULL
was	NULL
further	NULL
studied	NULL
by	NULL
using	NULL
a	NULL
combinational	NULL
mutagenesis	NULL
approach	NULL
in	NULL
which	NULL
a	NULL
series	NULL
of	NULL
double	NULL
mutants	NULL
were	NULL
produced	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
was	NULL
nearly	NULL
ablated	NULL
when	NULL
dual	NULL
mutations	NULL
were	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
Alu-CONTAINING	NULL
T-CELL-SPECIFIC	NULL
CD8	NULL
«	NULL
ENHANCER	NULL
7061	NULL
90	NULL
100	NULL
110	NULL
120	NULL
GGAGGCCGAG	NULL
CGTTGCAGTGA	NULL
GCTGAGATCG	NULL
TACCACTGCA	NULL
CTCCAGCCTG	NULL
CGTAACAGAG	NULL
CAAGATITCCA	NULL
TCTCACAAAA	NULL
130	NULL
140	NULL
150	NULL
160	NULL
170	NULL
180	NULL
190	NULL
200	NULL
210	NULL
220	NULL
230	NULL
240	NULL
AAAAAAAAAA	NULL
GTGGGGGGGG	NULL
AAGTTTTTAG	NULL
CTTTTCTTTT	NULL
CTTTTCTTTT	NULL
CTTTTITTTTT	NULL
TTTTTTTITTT	NULL
TTT	NULL
Tthl11-I	NULL
250	NULL
260	NULL
270	NULL
280	NULL
290	NULL
300	NULL
310	NULL
320	NULL
CA	NULL
GATA-3	NULL
330	NULL
340	NULL
350	NULL
360	NULL
370	NULL
380	NULL
390	NULL
400	NULL
TA	NULL
LyF-1	NULL
410	NULL
420	NULL
430	NULL
440	NULL
450	NULL
460	NULL
470	NULL
480	NULL
G	NULL
bELH	NULL
LyF-1	NULL
490	NULL
500	NULL
510	NULL
520	NULL
530	NULL
540	NULL
550	NULL
560	NULL
CTGGGATTAT	NULL
AGGCGTGAGC	NULL
TACCGCACCC	NULL
GGCCAGTTTT	NULL
TAGCATTTTT	NULL
ATTATICAGG	NULL
GTGCACTTTG	NULL
GAACTTTTGC	NULL
570	NULL
580	NULL
590	NULL
600	NULL
AGAAGGACCA	NULL
TCCCTTTTCT	NULL
CGATCTTTTC	NULL
TGAAAACTCT	NULL
CATTGTGAGA	NULL
TGAATAACTG	NULL
AGAATAAAGT	NULL
TCTGCCTTAA	NULL
650	NULL
660	NULL
670	NULL
680	NULL
610	NULL
620	NULL
630	NULL
640	NULL
TCF-1	NULL
690	NULL
700	NULL
710	NULL
720	NULL
AATACAAAGC	NULL
TATACAGATT	NULL
AAACACACCT	NULL
GGGAAATTCC	NULL
AACACCCGAG	NULL
TTAATATACT	NULL
CAGTGATGAT	NULL
GGTGGGCCGC	NULL
730	NULL
740	NULL
750	NULL
760	NULL
TCAGCTTCAA	NULL
CAGAGAGGTT	NULL
TTAGAGGGCT	NULL
GAGAGTGCAG	NULL
ACATGACGTC	NULL
ATGATGAATT	NULL
AGCATGTTTA	NULL
CAAGGTGCTA	NULL
810	NULL
820	NULL
830	NULL
840	NULL
770	NULL
780	NULL
790	NULL
800	NULL
CRE	NULL
850	NULL
860	NULL
870	NULL
880	NULL
GCCTGGTGCT	NULL
GAATTAACAC	NULL
GTTTTTAGCG	NULL
TAACATCATT	NULL
TGGCTGATGG	NULL
TGGTGATTITG	NULL
CTCACATCCT	NULL
CCTCTCTCCC	NULL
890	NULL
900	NULL
910	NULL
TGTCATCCTC	NULL
CGGGGCTGAG	NULL
AATCAGGTCA	NULL
A-280	NULL
A	NULL
Ets-1	NULL
FIG	NULL
.	NULL

1-Continued	NULL
.	NULL

introduced	NULL
into	NULL
the	NULL
GATA-3/LyF-lu	NULL
,	NULL
LyF-lu/LyF-1d	NULL
,	NULL
and	NULL
bHLH/LyF-1d	NULL
sites	NULL
.	NULL

A	NULL
significant	NULL
loss	NULL
of	NULL
enhancer	NULL
function	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
bHLH/TCF-1	NULL
and	NULL
bHLH/CRE	NULL
double	NULL
mutants	NULL
,	NULL
whereas	NULL
mutational	NULL
combinations	NULL
of	NULL
the	NULL
LyF-lu/	NULL
bHLH	NULL
,	NULL
LyF-1u/CRE	NULL
,	NULL
LyF-1d/ITCF-1	NULL
,	NULL
and	NULL
LyF-1d/CRE	NULL
sites	NULL
had	NULL
very	NULL
little	NULL
effect	NULL
compared	NULL
with	NULL
single	NULL
mutants	NULL
for	NULL
each	NULL
individual	NULL
site	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
mutational	NULL
analysis	NULL
indicate	NULL
that	NULL
a	NULL
functional	NULL
hierarchy	NULL
exists	NULL
among	NULL
the	NULL
putative	NULL
cis-acting	NULL
elements	NULL
,	NULL
with	NULL
the	NULL
Ets-1	NULL
and	NULL
GATA-3	NULL
sites	NULL
appearing	NULL
most	NULL
important	NULL
to	NULL
CD8	NULL
«	NULL
intronic	NULL
enhancer	NULL
function	NULL
in	NULL
the	NULL
T-cell	NULL
lines	NULL
that	NULL
were	NULL
analyzed	NULL
.	NULL

Characterization	NULL
of	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
individual	NULL
cis-acting	NULL
elements	NULL
within	NULL
the	NULL
CD8	NULL
«	NULL
enhancer	NULL
by	NULL
EMSA	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
individual	NULL
protein	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
minimal	NULL
CD8a	NULL
«	NULL
enhancer	NULL
,	NULL
EMSA	NULL
were	NULL
performed	NULL
with	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
LyF-1	NULL
,	NULL
TCF-1	NULL
,	NULL
GATA-3	NULL
,	NULL
and	NULL
Ets-1	NULL
binding	NULL
sites	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
,	NULL
formed	NULL
by	NULL
incubation	NULL
of	NULL
labeled	NULL
synthetic	NULL
oligonucleotides	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
T-	NULL
and	NULL
non-T-cell	NULL
lines	NULL
,	NULL
were	NULL
resolved	NULL
by	NULL
using	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
specific	NULL
protein-DNA	NULL
interactions	NULL
were	NULL
identified	NULL
by	NULL
the	NULL
ability	NULL
to	NULL
block	NULL
complex	NULL
formation	NULL
with	NULL
competing	NULL
wild-type	NULL
oligonucleotides	NULL
but	NULL
not	NULL
with	NULL
mutant	NULL
oligonucleotides	NULL
.	NULL

These	NULL
mutant	NULL
oligonucleotides	NULL
,	NULL
containing	NULL
changes	NULL
in	NULL
the	NULL
consensus	NULL
core	NULL
motif	NULL
for	NULL
each	NULL
binding	NULL
site	NULL
,	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
previously	NULL
used	NULL
in	NULL
the	NULL
mutational	NULL
analysis	NULL
of	NULL
the	NULL
minimal	NULL
CD8a	NULL
enhancer	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
protein	NULL
LyF-1	NULL
,	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
core	NULL
consensus	NULL
sequence	NULL
5'-YYTGGGAGR-3	NULL
'	NULL
(	NULL
Interna-tional	NULL
Union	NULL
of	NULL
Biochemistry	NULL
[	NULL
IUB	NULL
]	NULL
nucleotide	NULL
code	NULL
)	NULL
,	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
a	NULL
general	NULL
transcription	NULL
factor	NULL
for	NULL
genes	NULL
whose	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
lymphoid	NULL
lineages	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Sequence	NULL
comparison	NULL
of	NULL
the	NULL
putative	NULL
upstream	NULL
and	NULL
downstream	NULL
LyF-1	NULL
sites	NULL
(	NULL
LyF-1u	NULL
and	NULL
LyF-1d	NULL
,	NULL
respectively	NULL
)	NULL
in	NULL
the	NULL
CD8a	NULL
enhancer	NULL
revealed	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
homology	NULL
with	NULL
one	NULL
another	NULL
as	NULL
well	NULL
as	NULL
with	NULL
previously	NULL
described	NULL
LyF-1	NULL
sites	NULL
in	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
other	NULL
lymphoid	NULL
cell-specific	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
a	NULL
P-labeled	NULL
oligonucleotide	NULL
7062	NULL
HAMBOR	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
.	NULL

B.	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bor	NULL
.	NULL

Plasmid	NULL
pTKLux	NULL
«	NULL
fmm	NULL
D8	NULL
ENHANCER	NULL
pTKCDBU-fommmmemmm	NULL
-at	NULL
or	NULL
a	NULL
r	NULL
a	NULL
oor	NULL
iii	NULL
}	NULL
pTKCD8D+	NULL
haes	NULL
pTKCD8D-	NULL
0	NULL
10	NULL
20	NULL
30	NULL
Relative	NULL
Activity	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Orientation	NULL
and	NULL
position	NULL
independence	NULL
of	NULL
the	NULL
T-cell-specific	NULL
CD8a	NULL
intronic	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
1,149-bp	NULL
Sp/hI-XmnI	NULL
fragment	NULL
from	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
human	NULL
CD8	NULL
«	NULL
gene	NULL
(	NULL
black	NULL
box	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
for	NULL
fragment	NULL
origin	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
luciferase-reporter	NULL
plasmid	NULL
pTKLux	NULL
in	NULL
both	NULL
orientations	NULL
(	NULL
-	NULL
and	NULL
+	NULL
;	NULL
note	NULL
arrows	NULL
over	NULL
the	NULL
black	NULL
enhancer	NULL
box	NULL
)	NULL
both	NULL
upstream	NULL
(	NULL
U	NULL
)	NULL
and	NULL
downstream	NULL
(	NULL
D	NULL
)	NULL
of	NULL
a	NULL
minimal	NULL
heterologous	NULL
promoter	NULL
from	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
TK	NULL
gene	NULL
(	NULL
open	NULL
box	NULL
with	NULL
arrowhead	NULL
)	NULL
.	NULL

In	NULL
all	NULL
of	NULL
the	NULL
constructs	NULL
,	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
(	NULL
speckled	NULL
box	NULL
)	NULL
is	NULL
used	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
whose	NULL
mRNA	NULL
is	NULL
stabilized	NULL
by	NULL
a	NULL
polyadenylation/splice	NULL
signal	NULL
from	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
cross-hatched	NULL
box	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
,	NULL
Jurkat	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
above	NULL
constructs	NULL
and	NULL
with	NULL
the	NULL
plasmid	NULL
pCMVB-gal	NULL
and	NULL
then	NULL
assayed	NULL
for	NULL
both	NULL
B-galactosidase	NULL
and	NULL
luciferase	NULL
activities	NULL
40	NULL
to	NULL
48	NULL
h	NULL
later	NULL
.	NULL

To	NULL
adjust	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
,	NULL
luciferase	NULL
values	NULL
were	NULL
standardized	NULL
to	NULL
B-galactosidase	NULL
values	NULL
.	NULL

Relative	NULL
activities	NULL
of	NULL
plasmids	NULL
with	NULL
the	NULL
1,149-bp	NULL
CD8	NULL
fragment	NULL
(	NULL
pTKCD8U-	NULL
,	NULL
pTKCD8D+	NULL
,	NULL
and	NULL
pTKCD8D-	NULL
)	NULL
were	NULL
determined	NULL
by	NULL
normalizing	NULL
these	NULL
standardized	NULL
values	NULL
to	NULL
pTKLux	NULL
.	NULL

probe	NULL
containing	NULL
the	NULL
LyF-1d	NULL
site	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
T-cell	NULL
lines	NULL
Molt4	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
HPB.ALL	NULL
,	NULL
as	NULL
well	NULL
as	NULL
from	NULL
the	NULL
B-cell	NULL
line	NULL
Raji	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
not	NULL
from	NULL
the	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
HeLa	NULL
and	NULL
HepG2	NULL
,	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
single	NULL
protein-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
was	NULL
effectively	NULL
prevented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
unlabeled	NULL
specific	NULL
competitor	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
wild-type	NULL
LyF-1d	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
in	NULL
which	NULL
the	NULL
LyF-1d	NULL
site	NULL
had	NULL
been	NULL
mutated	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

EMSA	NULL
using	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
LyF-1u	NULL
site	NULL
also	NULL
produced	NULL
a	NULL
similar	NULL
protein-DNA	NULL
complex	NULL
that	NULL
could	NULL
be	NULL
specifically	NULL
inhibited	NULL
by	NULL
the	NULL
wild-type	NULL
,	NULL
but	NULL
not	NULL
the	NULL
mutant	NULL
,	NULL
LyF-1u	NULL
oligonucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
LyF-lu	NULL
and	NULL
LyF-1d	NULL
sites	NULL
could	NULL
cross-compete	NULL
in	NULL
these	NULL
assays	NULL
,	NULL
indicating	NULL
that	NULL
each	NULL
site	NULL
was	NULL
binding	NULL
a	NULL
common	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Two	NULL
distinct	NULL
lymphoid	NULL
cell-restricted	NULL
transcription	NULL
factors	NULL
,	NULL
TCF-1	NULL
and	NULL
TCF-la	NULL
«	NULL
(	NULL
or	NULL
LEF-1	NULL
)	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
bind	NULL
to	NULL
an	NULL
identical	NULL
pyrimidine-rich	NULL
sequence	NULL
(	NULL
5'-Y¥CTCTK	NULL
WW-3	NULL
'	NULL
;	NULL
IUB	NULL
nucleotide	NULL
code	NULL
)	NULL
found	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
a	NULL
number	NULL
of	NULL
lymphoid	NULL
cell-specific	NULL
genes	NULL
(	NULL
45	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
CD8a	NULL
enhancer	NULL
revealed	NULL
a	NULL
homologous	NULL
sequence	NULL
which	NULL
could	NULL
function	NULL
as	NULL
a	NULL
TCF-1	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

EMSA	NULL
using	NULL
an	NULL
oligonucleotide	NULL
from	NULL
the	NULL
CD8a	NULL
«	NULL
enhancer	NULL
containing	NULL
the	NULL
putative	NULL
TCF-1	NULL
site	NULL
demonstrated	NULL
that	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
T-cell	NULL
lines	NULL
Molt4	NULL
,	NULL
HPB.ALL	NULL
,	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
,	NULL
and	NULL
Jurkat	NULL
contained	NULL
two	NULL
DNA-binding	NULL
activities	NULL
with	NULL
different	NULL
electrophoretic	NULL
mobilities	NULL
resulting	NULL
in	NULL
the	NULL
resolution	NULL
of	NULL
two	NULL
distinct	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
only	NULL
the	NULL
lower	NULL
band	NULL
representing	NULL
a	NULL
faster	NULL
mobility	NULL
complex	NULL
was	NULL
formed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
non-T-cell	NULL
lines	NULL
HeLa	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
Raji	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
using	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
wild-type	NULL
and	NULL
mutant	NULL
TCF-1	NULL
sites	NULL
demonstrated	NULL
that	NULL
the	NULL
slower	NULL
mobility	NULL
complex	NULL
(	NULL
upper	NULL
band	NULL
;	NULL
see	NULL
arrow	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
contained	NULL
a	NULL
specific	NULL
DNA-binding	NULL
activity	NULL
that	NULL
was	NULL
present	NULL
only	NULL
in	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
represents	NULL
a	NULL
nonspecific	NULL
DNA-binding	NULL
activity	NULL
that	NULL
was	NULL
present	NULL
in	NULL
all	NULL
nuclear	NULL
extracts	NULL
tested	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
represented	NULL
by	NULL
the	NULL
upper	NULL
band	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
a	NULL
previously	NULL
described	NULL
oligonucleotide	NULL
(	NULL
79	NULL
)	NULL
from	NULL
the	NULL
CD3s	NULL
enhancer	NULL
(	NULL
MWS56	NULL
)	NULL
which	NULL
contains	NULL
a	NULL
TCF-1	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
CD8	NULL
«	NULL
enhancer	NULL
contains	NULL
a	NULL
TCF-1	NULL
binding	NULL
site	NULL
which	NULL
is	NULL
equivalent	NULL
to	NULL
the	NULL
one	NULL
found	NULL
in	NULL
the	NULL
CD3s	NULL
enhancer	NULL
.	NULL

The	NULL
CD8	NULL
«	NULL
enhancer	NULL
also	NULL
contains	NULL
a	NULL
consensus	NULL
motif	NULL
(	NULL
5'-WGATAR-3	NULL
'	NULL
;	NULL
IUB	NULL
nucleotide	NULL
code	NULL
)	NULL
for	NULL
a	NULL
GATA	NULL
binding	NULL
protein	NULL
.	NULL

A	NULL
T-cell-restricted	NULL
GATA	NULL
binding	NULL
protein	NULL
,	NULL
GATA-3	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
specifically	NULL
bind	NULL
to	NULL
this	NULL
motif	NULL
(	NULL
37	NULL
)	NULL
.	NULL

EMSA	NULL
using	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
GATA-3	NULL
motif	NULL
revealed	NULL
a	NULL
very	NULL
slow	NULL
mobility	NULL
complex	NULL
(	NULL
see	NULL
arrow	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
which	NULL
only	NULL
formed	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
T-cell	NULL
lines	NULL
Jurkat	NULL
,	NULL
Molt4	NULL
,	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
,	NULL
and	NULL
HPB.ALL	NULL
.	NULL

Cold	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
A	NULL
3	NULL
'	NULL
END	NULL
100	NULL
bp	NULL
a-	NULL
3	NULL
'	NULL
A-95	NULL
-a-	NULL
3'A219	NULL
-a-	NULL
3	NULL
'	NULL
A-250	NULL
-a-	NULL
3	NULL
'	NULL
A-280	NULL
a	NULL
sy	NULL
Ets-1	NULL
-	NULL
SR	NULL
_	NULL
ggg	NULL
»	NULL
CRE	NULL
«	NULL
a	NULL
--	NULL
3	NULL
'	NULL
A-510	NULL
Tcri	NULL
am	NULL
LyF-1	NULL
bHLH	NULL
5	NULL
-a-	NULL
5	NULL
'	NULL
A-389	NULL
LyF-1	NULL
|	NULL
H	NULL
-a-	NULL
5	NULL
'	NULL
A-290	NULL
GATA-3	NULL
|	NULL
S5	NULL
..	NULL
==	NULL
$	NULL
803	NULL
«	NULL
a-	NULL
5	NULL
'	NULL
A-18	NULL
5°	NULL
END	NULL
Alu-CONTAINING	NULL
T-CELL-SPECIFIC	NULL
CD8	NULL
«	NULL
ENHANCER	NULL
Deletions	NULL
of	NULL
CD8	NULL
Enhancer	NULL
from	NULL
3	NULL
'	NULL
End	NULL
Plasmid	NULL
pTKCDpsu+	NULL
F	NULL
22	NULL
peazig	NULL
22A	NULL
paaeso	NULL
22	NULL
para	NULL
2	NULL
p3	NULL
'	NULL
A-332	NULL
Jurkat	NULL
p3	NULL
'	NULL
A-510	NULL
m	NULL
JM	NULL
o	NULL
20	NULL
40	NULL
60	NULL
so	NULL
100	NULL
Relative	NULL
Activity	NULL
Deletions	NULL
of	NULL
CD8	NULL
Enhancer	NULL
from	NULL
5	NULL
``	NULL
End	NULL
p5	NULL
'	NULL
A-389	NULL
p5	NULL
'	NULL
A-290	NULL
p5	NULL
'	NULL
A-204	NULL
p5	NULL
'	NULL
A-203	NULL
p5'A18	NULL
pTkcosu-	NULL
|	NULL
T	NULL
u	NULL
T	NULL
T	NULL
T	NULL
0	NULL
20	NULL
40	NULL
60	NULL
so	NULL
100	NULL
Relative	NULL
Activity	NULL
7063	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Deletional	NULL
analysis	NULL
of	NULL
the	NULL
CD8a	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
extent	NULL
of	NULL
unidirectional	NULL
exonuclease	NULL
III	NULL
deletions	NULL
from	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
1,149-bp	NULL
enhancer	NULL
fragment	NULL
is	NULL
shown	NULL
by	NULL
horizontal	NULL
arrows	NULL
pointing	NULL
to	NULL
the	NULL
site	NULL
of	NULL
deletion	NULL
.	NULL

Also	NULL
depicted	NULL
are	NULL
the	NULL
consensus	NULL
motifs	NULL
for	NULL
GATA-3	NULL
,	NULL
LyF-1	NULL
,	NULL
bHLH	NULL
,	NULL
TCF-1	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
Ets-1	NULL
binding	NULL
proteins	NULL
.	NULL

The	NULL
vertical	NULL
arrows	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
fragment	NULL
represent	NULL
an	NULL
inverted	NULL
repeat	NULL
that	NULL
is	NULL
formed	NULL
by	NULL
the	NULL
Alu	NULL
sequences	NULL
.	NULL

A	NULL
100-bp	NULL
size	NULL
marker	NULL
is	NULL
also	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Functional	NULL
analysis	NULL
of	NULL
deletion	NULL
mutants	NULL
from	NULL
the	NULL
3	NULL
'	NULL
end	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
plasmid	NULL
pTKCD8U+	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
3	NULL
'	NULL
deletion	NULL
mutants	NULL
is	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Functional	NULL
analysis	NULL
of	NULL
deletion	NULL
mutants	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
plasmid	NULL
pTKCD8U-	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
5	NULL
'	NULL
deletion	NULL
mutants	NULL
is	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Jurkat	NULL
and	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
deletion	NULL
constructs	NULL
and	NULL
the	NULL
reference	NULL
plasmid	NULL
pCMVB-gal	NULL
.	NULL

Relative	NULL
activity	NULL
was	NULL
calculated	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
name	NULL
of	NULL
each	NULL
plasmid	NULL
denotes	NULL
the	NULL
end	NULL
from	NULL
which	NULL
the	NULL
deletion	NULL
was	NULL
made	NULL
and	NULL
the	NULL
exact	NULL
amount	NULL
of	NULL
sequence	NULL
that	NULL
was	NULL
deleted	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
the	NULL
plasmid	NULL
p3	NULL
'	NULL
A-280	NULL
,	NULL
the	NULL
CD8a	NULL
enhancer	NULL
was	NULL
deleted	NULL
280	NULL
bp	NULL
from	NULL
the	NULL
3	NULL
'	NULL
end	NULL
.	NULL

7064	NULL
HAMBOR	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CEL	NULL
.	NULL

®	NULL
Plasmid	NULL
Yur	NULL
0	NULL
ig	NULL
A	NULL
A	NULL
}	NULL
men	NULL
.	NULL

fF	NULL
$	NULL
o	NULL
SL	NULL
<	NULL
4	NULL
&	NULL
&	NULL
yarso	NULL
pTKLux	NULL
gi	NULL
0	NULL
Sug	NULL
g	NULL
EL	NULL
{	NULL
}	NULL
{	NULL
--	NULL
-	NULL
[	NULL
T	NULL
prkoosu	NULL
.	NULL

2	NULL
ooo	NULL
-O-D	NULL
--	NULL
OO	NULL
--	NULL
O	NULL
--	NULL
1-D-	NULL
~	NULL
~~	NULL
[	NULL
TK	NULL
)	NULL
pTKGDBmin	NULL
Single	NULL
Mutants	NULL
4-O	NULL
--	NULL
OO	NULL
--	NULL
O	NULL
--	NULL
O-	NULL
{	NULL
-	NULL
~	NULL
~~	NULL
[	NULL
TK	NULL
)	NULL
pmeatas	NULL
pmiyriu	NULL
P	NULL
-O	NULL
--	NULL
O	NULL
--	NULL
KO	NULL
--	NULL
-O	NULL
--	NULL
-t	NULL
--	NULL
+	NULL
pmbHLH	NULL
moo	NULL
-O-O	NULL
--	NULL
O	NULL
#	NULL
--	NULL
O	NULL
--	NULL
O-O-	NULL
poly-	NULL
10	NULL
rrr	NULL
O-O	NULL
--	NULL
0O0	NULL
--	NULL
I	NULL
#	NULL
--	NULL
O	NULL
--	NULL
pmTor1	NULL
oars	NULL
.	NULL
``	NULL

pmone	NULL
eam	NULL
pmets-1	NULL
@	NULL
i	NULL
Double	NULL
Mutants	NULL
4-I	NULL
--	NULL
-OQ	NULL
--	NULL
{	NULL
--	NULL
-UJ-F-	NULL
pmGATA-3/LyF-1u	NULL
.	NULL

\	NULL
-O-K	NULL
--	NULL
KH	NULL
}	NULL
--	NULL
-O	NULL
--	NULL
-t	NULL
--	NULL
F	NULL
Pee	NULL
-	NULL
«	NULL
O-B	NULL
--	NULL
O	NULL
--	NULL
-O	NULL
--	NULL
-OJ	NULL
--	NULL
F-	NULL
pmLyF-1wLyF-10	NULL
.	NULL

-O	NULL
--	NULL
K	NULL
--	NULL
-OO	NULL
--	NULL
-O	NULL
--	NULL
AI	NULL
--	NULL
-	NULL
pmilyr1wone	NULL
P	NULL
o	NULL
-	NULL
«	NULL
O-O	NULL
--	NULL
M	NULL
--	NULL
-DO	NULL
--	NULL
UO	NULL
--	NULL
-	NULL
pmbHLH/LyF-10	NULL
.	NULL

(	NULL
Wi	NULL
pmphietcra	NULL
AZZ	NULL
-	NULL
«	NULL
O-O	NULL
--	NULL
BO	NULL
--	NULL
O	NULL
--	NULL
I	NULL
--	NULL
pmpriwons	NULL
rrr	NULL
rrr	NULL
ror	NULL
rrr	NULL
orr	NULL
rare	NULL
-O-L	NULL
--	NULL
-HMR	NULL
--	NULL
AB	NULL
--	NULL
O	NULL
--	NULL
}	NULL
pmLyFAd4TCF-1	NULL
ans	NULL
-O	NULL
--	NULL
O	NULL
--	NULL
-O	NULL
#	NULL
--	NULL
-O	NULL
--	NULL
AAI	NULL
--	NULL
-	NULL
pmiyr14ione	NULL
P	NULL
m	NULL
m	NULL
®	NULL
A	NULL
A	NULL
A	NULL
A	NULL
I	NULL
``	NULL
I	NULL
``	NULL
I	NULL
``	NULL
I	NULL
``	NULL
I	NULL
CC	NULL
PF	NULL
£	NULL
4	NULL
&	NULL
®	NULL
Y	NULL
&	NULL
V	NULL
as	NULL
0	NULL
25	NULL
50	NULL
75	NULL
100	NULL
Relative	NULL
Activity	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
minimal	NULL
CD8a	NULL
«	NULL
enhancer	NULL
.	NULL

The	NULL
minimal	NULL
CD8	NULL
«	NULL
enhancer	NULL
(	NULL
pTKCD	NULL
$	NULL
8	NULL
min	NULL
)	NULL
,	NULL
defined	NULL
on	NULL
the	NULL
5	NULL
'	NULL
end	NULL
by	NULL
a	NULL
Tth1111	NULL
site	NULL
representing	NULL
deletion	NULL
of	NULL
216	NULL
bp	NULL
and	NULL
on	NULL
the	NULL
3	NULL
'	NULL
end	NULL
by	NULL
a	NULL
3	NULL
'	NULL
A-280	NULL
site	NULL
representing	NULL
deletion	NULL
of	NULL
280	NULL
bp	NULL
,	NULL
is	NULL
depicted	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

Also	NULL
shown	NULL
are	NULL
the	NULL
consensus	NULL
nucleoprotein	NULL
binding	NULL
motifs	NULL
.	NULL

The	NULL
653-bp	NULL
minimal	NULL
enhancer	NULL
fragments	NULL
which	NULL
have	NULL
wild-type	NULL
(	NULL
open	NULL
box	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
solid	NULL
box	NULL
)	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
TK	NULL
promoter	NULL
in	NULL
its	NULL
native	NULL
5'-to-3	NULL
'	NULL
orientation	NULL
in	NULL
the	NULL
luciferase-reporter	NULL
plasmid	NULL
pTKLux	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
mutant	NULL
oligomers	NULL
used	NULL
to	NULL
introduce	NULL
these	NULL
site-directed	NULL
changes	NULL
into	NULL
the	NULL
minimal	NULL
enhancer	NULL
are	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
and	NULL
also	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

Both	NULL
single	NULL
and	NULL
double	NULL
mutants	NULL
were	NULL
generated	NULL
.	NULL

JM	NULL
(	NULL
G2	NULL
)	NULL
and	NULL
Jurkat	NULL
T-cell	NULL
lines	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
mutant	NULL
reporter	NULL
constructs	NULL
and	NULL
the	NULL
reference	NULL
plasmid	NULL
pCMVB-gal	NULL
.	NULL

Relative	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
normalizing	NULL
standardized	NULL
values	NULL
to	NULL
pTKCD8min	NULL
(	NULL
set	NULL
at	NULL
a	NULL
value	NULL
of	NULL
100	NULL
)	NULL
.	NULL

competition	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
demonstrated	NULL
that	NULL
this	NULL
more	NULL
slowly	NULL
migrating	NULL
complex	NULL
contains	NULL
a	NULL
GATA	NULL
binding	NULL
protein	NULL
specific	NULL
for	NULL
the	NULL
GATA	NULL
site	NULL
,	NULL
since	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
was	NULL
inhibited	NULL
only	NULL
by	NULL
the	NULL
wild-type	NULL
GATA	NULL
oligomer	NULL
.	NULL

Two	NULL
faster-migrating	NULL
,	NULL
nonspecific	NULL
complexes	NULL
were	NULL
also	NULL
observed	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
examined	NULL
that	NULL
were	NULL
not	NULL
inhibited	NULL
by	NULL
the	NULL
wild-type	NULL
GATA	NULL
oligomer	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
consensus	NULL
GATA-3	NULL
site	NULL
in	NULL
the	NULL
CD8a	NULL
enhancer	NULL
specifically	NULL
binds	NULL
a	NULL
T-cell-restricted	NULL
nuclear	NULL
factor	NULL
.	NULL

The	NULL
Ets-l	NULL
proto-oncogene	NULL
,	NULL
which	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
that	NULL
recognizes	NULL
the	NULL
consensus	NULL
motif	NULL
5'-RRSMGGAWVWR-3	NULL
'	NULL
(	NULL
IUB	NULL
nucleotide	NULL
code	NULL
)	NULL
,	NULL
is	NULL
preferentially	NULL
expressed	NULL
in	NULL
thymocytes	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
45	NULL
)	NULL
.	NULL

This	NULL
motif	NULL
,	NULL
found	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
other	NULL
T-cell-specific	NULL
genes	NULL
(	NULL
80	NULL
)	NULL
,	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
CD8	NULL
«	NULL
enhancer	NULL
.	NULL

A	NULL
cluster	NULL
of	NULL
three	NULL
T-cell-restricted	NULL
DNA-protein	NULL
complexes	NULL
was	NULL
formed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
T-cell	NULL
lines	NULL
Jurkat	NULL
,	NULL
Molt4	NULL
,	NULL
JIM	NULL
(	NULL
G2	NULL
)	NULL
,	NULL
and	NULL
HPB.ALL	NULL
(	NULL
see	NULL
bracketed	NULL
bands	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
but	NULL
not	NULL
from	NULL
the	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
HeLa	NULL
and	NULL
HepG2	NULL
or	NULL
from	NULL
the	NULL
B-cell	NULL
line	NULL
Raji	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
this	NULL
cluster	NULL
of	NULL
complexes	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
a	NULL
competitor	NULL
oligonucleotide	NULL
containing	NULL
an	NULL
Ets-1	NULL
consensus	NULL
sequence	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
related	NULL
oligonucleotide	NULL
in	NULL
which	NULL
the	NULL
Ets-1	NULL
motif	NULL
was	NULL
mutated	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
whether	NULL
the	NULL
observed	NULL
cluster	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
represents	NULL
the	NULL
modification	NULL
or	NULL
degradation	NULL
of	NULL
a	NULL
single	NULL
nucleoprotein	NULL
or	NULL
the	NULL
binding	NULL
of	NULL
three	NULL
unique	NULL
nucleoproteins	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
Ets-1	NULL
motif	NULL
in	NULL
the	NULL
CD8a	NULL
enhancer	NULL
also	NULL
appears	NULL
to	NULL
function	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
T-cell-specific	NULL
nuclear	NULL
factors	NULL
.	NULL

The	NULL
enhancer	NULL
is	NULL
partially	NULL
composed	NULL
of	NULL
an	NULL
A/z	NULL
repeat	NULL
.	NULL

Sequence	NULL
analysis	NULL
revealed	NULL
an	NULL
Alu	NULL
repeat	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
this	NULL
sequence	NULL
with	NULL
known	NULL
Alu	NULL
consensus	NULL
sequences	NULL
(	NULL
71	NULL
)	NULL
indicated	NULL
that	NULL
there	NULL
is	NULL
96	NULL
%	NULL
homology	NULL
to	NULL
the	NULL
precise	NULL
consensus	NULL
,	NULL
with	NULL
nucleotide	NULL
changes	NULL
at	NULL
only	NULL
12	NULL
positions	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Alu	NULL
family	NULL
members	NULL
with	NULL
characteristics	NULL
of	NULL
the	NULL
precise	NULL
consensus	NULL
are	NULL
believed	NULL
to	NULL
have	NULL
been	NULL
more	NULL
recently	NULL
inserted	NULL
into	NULL
the	NULL
ge-nome	NULL
.	NULL

Six	NULL
of	NULL
the	NULL
12	NULL
changes	NULL
from	NULL
the	NULL
precise	NULL
consensus	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
Consensus	NULL
5	NULL
``	NULL
-YYTGGGAGR-3	NULL
'	NULL
CD8	NULL
Enhancer	NULL
upstream	NULL
wild-type	NULL
GTCCCAGCTACTTGGGAGGTTGAGGCAGG	NULL
mutant	NULL
___	NULL
__	NULL
__	NULL
__	NULL
___	NULL
_	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
=-	NULL
GCAT-C	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
downstream	NULL
wild-type	NULL
ATCCCAGCACTTTGGGAGGCCAAGGCGGG	NULL
mutant	NULL
__	NULL
AGGCCT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
Related	NULL
Genes	NULL
hTdT	NULL
TATTGGACA	NULL
TTTGGCAGG	NULL
mTdT	NULL
TTTGGGAGA	NULL
TTCAGCAGG	NULL
hLCK	NULL
CCTGGGAGA	NULL
GTTGGGAGG	NULL
CCTGGGACA	NULL
Ccressceer	NULL
mLCK	NULL
TCTGGGGGA	NULL
TTTGGGGGA	NULL
Molt	NULL
4	NULL
ad	NULL
s	NULL
é	NULL
o	NULL
§	NULL
£	NULL
{	NULL
&	NULL
14°	NULL
%	NULL
¢	NULL
&	NULL
o	NULL
3	NULL
M	NULL
[	NULL
T	NULL
]	NULL
u	NULL
ML	NULL
-l	NULL
s	NULL
53	NULL
E	NULL
I	NULL
£	NULL
|	NULL
j	NULL
f	NULL
A	NULL
10	NULL
mn	NULL
@	NULL
!	NULL

471	NULL
§m0Ge	NULL
Zo	NULL
-B	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
the	NULL
downstream	NULL
LyF-1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
compares	NULL
the	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
LyF-1	NULL
binding	NULL
site	NULL
with	NULL
aligned	NULL
sequences	NULL
of	NULL
LyF-1	NULL
binding	NULL
sites	NULL
found	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
«	NULL
gene	NULL
and	NULL
other	NULL
related	NULL
T-cell-specific	NULL
genes	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
from	NULL
the	NULL
CD8a	NULL
enhancer	NULL
representing	NULL
the	NULL
upstream	NULL
(	NULL
positions	NULL
353	NULL
to	NULL
324	NULL
from	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
)	NULL
and	NULL
downstream	NULL
(	NULL
positions	NULL
487	NULL
to	NULL
458	NULL
from	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
)	NULL
wild-type	NULL
LyF-1	NULL
sites	NULL
and	NULL
flanking	NULL
sequence	NULL
,	NULL
as	NULL
well	NULL
as	NULL
oligonucleotides	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
upstream	NULL
and	NULL
downstream	NULL
LyF-1	NULL
binding	NULL
sites	NULL
,	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
dashes	NULL
indicate	NULL
identical	NULL
sequences	NULL
in	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
.	NULL

The	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
shows	NULL
an	NULL
EMSA	NULL
with	NULL
the	NULL
radiolabeled	NULL
wild-type	NULL
LyF-1	NULL
(	NULL
downstream	NULL
site	NULL
)	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
Molt4	NULL
,	NULL
Jurkat	NULL
,	NULL
HPB.ALL	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
HepG2	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
bands	NULL
of	NULL
altered	NULL
mobility	NULL
representing	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

Lanes	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
,	NULL
competition	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
Molt4	NULL
nuclear	NULL
extract	NULL
was	NULL
preincubated	NULL
(	NULL
5	NULL
min	NULL
)	NULL
with	NULL
either	NULL
no	NULL
competitor	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
with	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
w	NULL
;	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
m	NULL
;	NULL
lane	NULL
8	NULL
)	NULL
LyF-1	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

Alu-CONTAINING	NULL
T-CELL-SPECIFIC	NULL
CD8	NULL
«	NULL
ENHANCER	NULL
7065	NULL
Consensus	NULL
5	NULL
``	NULL
-Y¥CTYTEKWW-3	NULL
'	NULL
CD8	NULL
Enhancer	NULL
wild-type	NULL
TTTAAGGCAGAACTTTATTCTCAGTTATTCA	NULL
Mutant	NULL
___	NULL
________	NULL
_	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
ACCGCGG	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
Related	NULL
Genes	NULL
mCD4	NULL
TAGGCCCTTTGTT	NULL
TCRa	NULL
GGCACCCTTTGAA	NULL
TCRS	NULL
CCTCCCCTCTGAA	NULL
TCRSé	NULL
AAAGCCCTTTGAA	NULL
CD37	NULL
TGCCTTCTCTCAA	NULL
AGATGCCTTTTGT	NULL
CD36	NULL
GAAACACTTTCAA	NULL
AGCACCCTTACCC	NULL
CD3e	NULL
AGAGCGCTTTGTT	NULL
AGCACACTCTGCT	NULL
CD2	NULL
CTAACACTTTGGG	NULL
ADA	NULL
AGTCTCCTTTGTT	NULL
LCK	NULL
GGCCTCCTGTGAA	NULL
AAAAGCCTGTTTG	NULL
GAAACTCTCTGAA	NULL
GGATGTCTCATGT	NULL
-I	NULL
Jurkat	NULL
4	NULL
&	NULL
s	NULL
u	NULL
.	NULL

§	NULL
sig	NULL
f	NULL
1	NULL
59	NULL
s	NULL
&	NULL
§	NULL
G	NULL
P1	NULL
;	NULL
f	NULL
“	NULL
than	NULL
”	NULL
S	NULL
Siva	NULL
cits	NULL
1	NULL
C2	NULL
.	NULL

4	NULL
5	NULL
.	NULL

#	NULL
7-8	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
the	NULL
TCF-1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
compares	NULL
the	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
TCF-1	NULL
binding	NULL
site	NULL
with	NULL
aligned	NULL
sequences	NULL
of	NULL
the	NULL
TCF-1	NULL
binding	NULL
site	NULL
found	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CD8	NULL
«	NULL
gene	NULL
and	NULL
other	NULL
related	NULL
T-cell-specific	NULL
genes	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
from	NULL
the	NULL
CD8a	NULL
«	NULL
enhancer	NULL
representing	NULL
the	NULL
wild-type	NULL
TCF-1	NULL
site	NULL
(	NULL
positions	NULL
641	NULL
to	NULL
611	NULL
from	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
)	NULL
and	NULL
mutant	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
dashes	NULL
indicate	NULL
identical	NULL
sequences	NULL
in	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
.	NULL

The	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
shows	NULL
an	NULL
EMSA	NULL
with	NULL
the	NULL
radiolabeled	NULL
wild-type	NULL
TCF-1	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
Molt4	NULL
,	NULL
HPB.ALL	NULL
,	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
HeLa	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
bands	NULL
of	NULL
altered	NULL
mobility	NULL
representing	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

Lanes	NULL
6	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
,	NULL
competition	NULL
experiments	NULL
in	NULL
which	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
was	NULL
preincubated	NULL
(	NULL
5	NULL
min	NULL
)	NULL
with	NULL
either	NULL
no	NULL
competitor	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
with	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
w	NULL
;	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
m	NULL
;	NULL
lane	NULL
8	NULL
)	NULL
TCF-1	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

occurred	NULL
at	NULL
CG	NULL
dinucleotides	NULL
,	NULL
which	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
an	NULL
accelerated	NULL
transition	NULL
rate	NULL
of	NULL
C	NULL
to	NULL
T	NULL
due	NULL
to	NULL
CG	NULL
methyla-tion	NULL
.	NULL

Four	NULL
of	NULL
the	NULL
protein	NULL
binding	NULL
sites	NULL
we	NULL
have	NULL
described	NULL
are	NULL
present	NULL
within	NULL
this	NULL
4/u	NULL
repeat	NULL
.	NULL

While	NULL
one	NULL
of	NULL
the	NULL
LyF-l	NULL
binding	NULL
sites	NULL
is	NULL
exactly	NULL
conserved	NULL
in	NULL
all	NULL
Alu	NULL
consensus	NULL
sequences	NULL
(	NULL
positions	NULL
38	NULL
to	NULL
46	NULL
)	NULL
,	NULL
the	NULL
other	NULL
LyF-1	NULL
site	NULL
(	NULL
positions	NULL
172	NULL
to	NULL
180	NULL
)	NULL
arose	NULL
by	NULL
a	NULL
single	NULL
C-to-T	NULL
change	NULL
at	NULL
position	NULL
174	NULL
corresponding	NULL
to	NULL
a	NULL
CG	NULL
dinucleotide	NULL
.	NULL

It	NULL
is	NULL
unknown	NULL
whether	NULL
this	NULL
change	NULL
,	NULL
a	NULL
characteristic	NULL
of	NULL
all	NULL
polymorphic	NULL
7066	NULL
HAMBOR	NULL
ET	NULL
AL	NULL
.	NULL

Consensus	NULL
5	NULL
``	NULL
-WGATAR-3	NULL
'	NULL
CD8	NULL
Enhancer	NULL
wild-type	NULL
TCCAGCCTGGGCGAGATAGCGAGACTCCGTC	NULL
MUt	NULL
@	NULL
nt	NULL
=_	NULL
_______	NULL
_	NULL
-	NULL
<	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
~	NULL
--	NULL
-	NULL
AGCTT	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
Related	NULL
Genes	NULL
TCRa	NULL
TAGATAGC	NULL
TCRB	NULL
GAGATAAA	NULL
TCRSé	NULL
TTGATAAC	NULL
TTGATAAC	NULL
__	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
=	NULL
<	NULL
'	NULL
@	NULL
i	NULL
s	NULL
a	NULL
<	NULL
-o-f	NULL
Piff	NULL
.	NULL

f	NULL
:	NULL
i	NULL
2	NULL
E	NULL
5	NULL
s	NULL
E	NULL
I	NULL
|	NULL
&	NULL
E	NULL
dnl	NULL
Wows	NULL
Ned	NULL
bent	NULL
<	NULL
1002	NULL
.	NULL

3.	NULL
iq	NULL
a-	NULL
50	NULL
Gi	NULL
7	NULL
ig	NULL
.	NULL

ig	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
the	NULL
GATA-3	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
compares	NULL
the	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
GATA-3	NULL
binding	NULL
site	NULL
with	NULL
aligned	NULL
sequences	NULL
of	NULL
GATA-3	NULL
binding	NULL
sites	NULL
found	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
gene	NULL
and	NULL
other	NULL
related	NULL
T-cell-specific	NULL
genes	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
from	NULL
the	NULL
CD8a	NULL
«	NULL
enhancer	NULL
representing	NULL
the	NULL
wild-type	NULL
GATA-3	NULL
site	NULL
(	NULL
positions	NULL
266	NULL
to	NULL
235	NULL
from	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
)	NULL
and	NULL
mutant	NULL
are	NULL
shown	NULL
.	NULL

Dashes	NULL
indicate	NULL
identical	NULL
sequences	NULL
in	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
.	NULL

The	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
shows	NULL
an	NULL
EMSA	NULL
with	NULL
the	NULL
radiolabeled	NULL
wild-type	NULL
GATA-3	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
HepG2	NULL
,	NULL
HeLa	NULL
,	NULL
Jurkat	NULL
,	NULL
Molt4	NULL
,	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
,	NULL
and	NULL
HPB	NULL
.	NULL

ALL	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
bands	NULL
of	NULL
altered	NULL
mobility	NULL
representing	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

Lanes	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
,	NULL
competition	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
nuclear	NULL
extract	NULL
was	NULL
preincubated	NULL
(	NULL
5	NULL
min	NULL
)	NULL
with	NULL
either	NULL
no	NULL
competitor	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
with	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
w	NULL
;	NULL
lane	NULL
8	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
m	NULL
;	NULL
lane	NULL
9	NULL
)	NULL
GATA-3	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

variant	NULL
(	NULL
PV	NULL
)	NULL
subfamily	NULL
members	NULL
,	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
this	NULL
functional	NULL
LyF-1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
other	NULL
two	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
bHLH	NULL
and	NULL
GATA-3	NULL
proteins	NULL
were	NULL
also	NULL
created	NULL
by	NULL
specific	NULL
mutations	NULL
from	NULL
the	NULL
precise	NULL
consensus	NULL
.	NULL

It	NULL
is	NULL
striking	NULL
that	NULL
of	NULL
the	NULL
12	NULL
bp	NULL
differences	NULL
between	NULL
the	NULL
precise	NULL
consensus	NULL
4/u	NULL
and	NULL
the	NULL
Alu	NULL
sequence	NULL
in	NULL
the	NULL
CD8	NULL
«	NULL
enhancer	NULL
,	NULL
four	NULL
are	NULL
in	NULL
positions	NULL
leading	NULL
to	NULL
the	NULL
creation	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
suggesting	NULL
that	NULL
selection	NULL
potentially	NULL
maintains	NULL
the	NULL
functionality	NULL
of	NULL
these	NULL
motifs	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
full-length	NULL
4/4	NULL
,	NULL
there	NULL
is	NULL
half	NULL
of	NULL
an	NULL
Alu	NULL
Mor	NULL
.	NULL

CEL	NULL
.	NULL

BioL	NULL
.	NULL

Consensus	NULL
5	NULL
-RRSMGGAWVWR-3	NULL
'	NULL
CD8	NULL
Enhancer	NULL
wild-type	NULL
TGACAGGGAGAGAGGAGGATGTGAGCAAATC	NULL
mutant	NULL
-	NULL
-CATATG	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-Related	NULL
Genes	NULL
TCRa	NULL
CAGAGGATGTG	NULL
TCRB	NULL
ACCAGGATGTC	NULL
TCR	NULL
GAAAGGATTAG	NULL
GCAAGGAAACC	NULL
ACAAGGAAACC	NULL
CD37y6	NULL
TTGAGGATGAG	NULL
CD3e	NULL
TGAAGGAGGGA	NULL
CD2	NULL
CAGAGGAAAAA	NULL
ADA	NULL
GGGAGGATCAG	NULL
Molt4	NULL
_	NULL
]	NULL
<	NULL
I	NULL
i	NULL
T	NULL
bus	NULL
a	NULL
é	NULL
(	NULL
j	NULL
)	NULL
<	NULL
7	NULL
)	NULL
§	NULL
$	NULL
4	NULL
.	NULL

5k	NULL
f	NULL
.	NULL

$	NULL
5	NULL
E	NULL
é	NULL
)	NULL
3	NULL
s	NULL
E	NULL
T	NULL
|	NULL
3	NULL
E	NULL
JETS	NULL
les	NULL
ins	NULL
Win	NULL
,	NULL
#	NULL
s	NULL
1°	NULL
20	NULL
3	NULL
~a	NULL
``	NULL
pong	NULL
``	NULL
Fe	NULL
mea	NULL
s	NULL
:	NULL
10	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
the	NULL
Ets-l	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
compares	NULL
the	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
Ets-1	NULL
binding	NULL
site	NULL
with	NULL
aligned	NULL
sequences	NULL
of	NULL
Ets-1	NULL
binding	NULL
sites	NULL
found	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
gene	NULL
and	NULL
other	NULL
related	NULL
T-cell-specific	NULL
genes	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
from	NULL
the	NULL
CD8a	NULL
enhancer	NULL
representing	NULL
the	NULL
wild-type	NULL
Ets-1	NULL
site	NULL
(	NULL
positions	NULL
885	NULL
to	NULL
855	NULL
from	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
)	NULL
and	NULL
mutant	NULL
are	NULL
shown	NULL
.	NULL

Dashes	NULL
indicate	NULL
identical	NULL
sequences	NULL
in	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
.	NULL

The	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
figure	NULL
shows	NULL
an	NULL
EMSA	NULL
with	NULL
the	NULL
radiolabeled	NULL
wild-type	NULL
Ets-1	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
either	NULL
no	NULL
extract	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
HeLa	NULL
,	NULL
HepG2	NULL
,	NULL
Jurkat	NULL
,	NULL
Molt4	NULL
,	NULL
JM	NULL
(	NULL
G2	NULL
)	NULL
,	NULL
and	NULL
HPB	NULL
.	NULL

ALL	NULL
.	NULL

Bracket	NULL
indicates	NULL
bands	NULL
of	NULL
altered	NULL
mobility	NULL
representing	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

Lanes	NULL
8	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
,	NULL
competition	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
Molt4	NULL
nuclear	NULL
extract	NULL
was	NULL
preincubated	NULL
(	NULL
5	NULL
min	NULL
)	NULL
with	NULL
either	NULL
no	NULL
competitor	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
with	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
w	NULL
;	NULL
lane	NULL
8	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
m	NULL
;	NULL
lane	NULL
9	NULL
)	NULL
Ets-1	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

repeat	NULL
located	NULL
immediately	NULL
5	NULL
'	NULL
in	NULL
an	NULL
inverted	NULL
orientation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
half-4/u	NULL
repeat	NULL
is	NULL
more	NULL
similar	NULL
to	NULL
the	NULL
major	NULL
consensus	NULL
Alu	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
representative	NULL
of	NULL
older	NULL
Alu	NULL
family	NULL
members	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
more	NULL
recent	NULL
full-length	NULL
Alu	NULL
sequence	NULL
was	NULL
inserted	NULL
next	NULL
to	NULL
the	NULL
older	NULL
half-4/z	NULL
sequence	NULL
.	NULL

While	NULL
no	NULL
protein	NULL
binding	NULL
sites	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
half-4/u	NULL
sequence	NULL
by	NULL
computer	NULL
search	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
inverted	NULL
sequence	NULL
could	NULL
form	NULL
a	NULL
cruciform	NULL
structure	NULL
with	NULL
the	NULL
linked	NULL
Alu	NULL
repeat	NULL
Vou	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
Alu-CONTAINING	NULL
T-CELL-SPECIFIC	NULL
CD8	NULL
«	NULL
ENHANCER	NULL
7067	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.cr	NULL
.	NULL

kkk	NULL
}	NULL
.	NULL

Major	NULL
Consensus	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
PV	NULL
Consensus	NULL
GGCCGGGCGC	NULL
GGTGGCTCAC	NULL
GCCTGTAATC	NULL
CCAGCACTTT	NULL
GGGAGGCCGA	NULL
GGCGGGCGGA	NULL
TCAC—-GAGGTC	NULL
Precise	NULL
Consensus	NULL
...	NULL
...	NULL
.	NULL

T.	NULL
«	NULL
Aviv	NULL
v	NULL
vs	NULL
ok	NULL
k	NULL
k	NULL
k	NULL
e	NULL
e	NULL
e	NULL
ea	NULL
oe	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
ee	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
ea	NULL
e	NULL
Au	NULL
lvn	NULL
k	NULL
eee	NULL
ee	NULL
CCB	NULL
.	NULL

CD8	NULL
full-length	NULL
Alu	NULL
LyF-1	NULL
YYT	NULL
GGGAGR	NULL
bEHLH	NULL
CAN	NULL
NTG	NULL
80	NULL
90	NULL
100	NULL
110	NULL
120	NULL
130	NULL
140	NULL
...	NULL
..	NULL
T.	NULL
kk	NULL
.	NULL

ok	NULL
kkk	NULL
s	NULL
G.	NULL
v	NULL
kk	NULL
ok	NULL
Cv	NULL
vs	NULL
Pak	NULL
vv	NULL
k	NULL
k	NULL
e	NULL
eve	NULL
ee	NULL
aa	NULL
e	NULL
e	NULL
a	NULL
n	NULL
e	NULL
e	NULL
ee	NULL
ne	NULL
e	NULL
e	NULL
e	NULL
a	NULL
a	NULL
e	NULL
ee	NULL
e	NULL
ee	NULL
ee	NULL
ees	NULL
Major	NULL
Consensus	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
C.	NULL
...	NULL
..A.	NULL
PV	NULL
Consensus	NULL
...	NULL
...	NULL
...	NULL
.	NULL

Precise	NULL
Consensus	NULL
CD8	NULL
full-length	NULL
Alu	NULL
CD8	NULL
half	NULL
Alu	NULL
Major	NULL
Consensus	NULL
PV	NULL
Consensus	NULL
Precise	NULL
Consensus	NULL
CD8	NULL
full-length	NULL
Alu	NULL
150	NULL
160	NULL
170	NULL
180	NULL
...	NULL
...	NULL
...	NULL
.	NULL

&	NULL
CRY	NULL
...	NULL
...	NULL
lke	NULL
.	NULL

.e	NULL
keel	NULL
kere	NULL
erk	NULL
eck	NULL
.	NULL

.l	NULL
}	NULL
ccereercec	NULL
T..T	NULL
...	NULL
..	NULL
«	NULL
T	NULL
.	NULL

kaal	NULL
.	NULL

eek	NULL
...	NULL
.	NULL

..	NULL
T	NULL
...	NULL
...	NULL
CA	NULL
T.C	NULL
...	NULL
C.A	NULL
.	NULL

.A	NULL
...	NULL
GG	NULL
~ATT	NULL
LyF-1	NULL
YYTGGGAGR	NULL
220	NULL
230	NULL
240	NULL
250	NULL
...	NULL
...	NULL
.	NULL

G..	NULL
kkk	NULL
ease	NULL
ees	NULL
ake	NULL
eee	NULL
Pik	NULL
leke	NULL
reek	NULL
ke	NULL
elk	NULL
}	NULL
.	NULL

...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
..	NULL
C..	NULL
k	NULL
kaka	NULL
kk	NULL
eave	NULL
eek	NULL
es	NULL
GcAGTGAGCC	NULL
GAGATCGCGC	NULL
CACTGCACTC	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL

A.	NULL
ake	NULL
...	NULL
...	NULL
...	NULL
.	NULL

G..	NULL
PA.	NULL
.k	NULL
...	NULL
...	NULL
..	NULL
C..T	NULL
GT..	NULL
CD8	NULL
half	NULL
Alu	NULL
260	NULL
270	NULL
280	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL

Major	NULL
Consensus	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
...	NULL
.	NULL

PV	NULL
Consensus	NULL
Precise	NULL
Consensus	NULL
CD8	NULL
full-length	NULL
Alu	NULL
CD8	NULL
half	NULL
Alu	NULL
GATA-3	NULL
WGATAR	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Alignment	NULL
of	NULL
A4/u	NULL
consensus	NULL
sequences	NULL
with	NULL
the	NULL
A4/z	NULL
sequences	NULL
in	NULL
the	NULL
CD8a	NULL
intronic	NULL
enhancer	NULL
.	NULL

Alu	NULL
consensus	NULL
sequences	NULL
representing	NULL
major	NULL
,	NULL
polymorphic	NULL
variant	NULL
(	NULL
PV	NULL
)	NULL
,	NULL
and	NULL
precise	NULL
subfamily	NULL
members	NULL
(	NULL
71	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
full-length	NULL
and	NULL
half-4/u	NULL
sequences	NULL
,	NULL
in	NULL
the	NULL
CD8	NULL
intronic	NULL
enhancer	NULL
are	NULL
shown	NULL
.	NULL

Dots	NULL
indicate	NULL
identical	NULL
nucleotides	NULL
,	NULL
and	NULL
dashes	NULL
correspond	NULL
to	NULL
gaps	NULL
or	NULL
deletions	NULL
.	NULL

The	NULL
insertion	NULL
of	NULL
three	NULL
nucleotides	NULL
(	NULL
~ATT	NULL
)	NULL
into	NULL
the	NULL
CD8	NULL
half-4/u	NULL
sequence	NULL
at	NULL
position	NULL
142	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
LyF-1	NULL
,	NULL
bHLH	NULL
,	NULL
and	NULL
GATA-3	NULL
proteins	NULL
are	NULL
shown	NULL
in	NULL
boldface	NULL
type	NULL
and	NULL
have	NULL
been	NULL
aligned	NULL
to	NULL
the	NULL
Alu	NULL
consensus	NULL
sequences	NULL
.	NULL

(	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
homology	NULL
)	NULL
under	NULL
some	NULL
circumstances	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
such	NULL
a	NULL
secondary	NULL
structure	NULL
may	NULL
account	NULL
for	NULL
the	NULL
apparent	NULL
silencer	NULL
activity	NULL
we	NULL
detected	NULL
when	NULL
we	NULL
removed	NULL
the	NULL
half-4/u	NULL
repeat	NULL
during	NULL
our	NULL
deletional	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

This	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
fragment	NULL
did	NULL
not	NULL
display	NULL
silencer	NULL
activity	NULL
when	NULL
placed	NULL
at	NULL
a	NULL
distance	NULL
from	NULL
the	NULL
enhancer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
prominent	NULL
tissue-restricted	NULL
DNase	NULL
I	NULL
HS	NULL
in	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
gene	NULL
and	NULL
found	NULL
that	NULL
a	NULL
fragment	NULL
containing	NULL
this	NULL
site	NULL
exhibited	NULL
the	NULL
properties	NULL
of	NULL
a	NULL
T-cell-specific	NULL
transcriptional	NULL
enhancer	NULL
.	NULL

We	NULL
found	NULL
a	NULL
number	NULL
of	NULL
protein	NULL
binding	NULL
sites	NULL
(	NULL
Ets-1	NULL
,	NULL
GATA-3	NULL
,	NULL
LyF-1	NULL
,	NULL
TCF-1	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
bHLH	NULL
)	NULL
and	NULL
demonstrated	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
these	NULL
elements	NULL
in	NULL
both	NULL
a	NULL
nucleoprotein	NULL
binding	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
and	NULL
a	NULL
reporter-based	NULL
expression	NULL
assay	NULL
by	NULL
using	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
consensus	NULL
protein	NULL
binding	NULL
site	NULL
for	NULL
each	NULL
motif	NULL
.	NULL

A	NULL
minimal	NULL
653-bp	NULL
enhancer	NULL
with	NULL
maximal	NULL
activity	NULL
was	NULL
delimited	NULL
on	NULL
the	NULL
5¢	NULL
and	NULL
3	NULL
'	NULL
ends	NULL
by	NULL
consensus	NULL
GATA-3	NULL
and	NULL
Ets-1	NULL
binding	NULL
sites	NULL
,	NULL
respectively	NULL
,	NULL
both	NULL
of	NULL
which	NULL
were	NULL
critical	NULL
for	NULL
enhancer	NULL
function	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
encoded	NULL
an	NULL
Alu	NULL
repeat	NULL
which	NULL
contained	NULL
four	NULL
consensus	NULL
motifs	NULL
for	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Deletion	NULL
experiments	NULL
suggested	NULL
that	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
containing	NULL
at	NULL
least	NULL
half	NULL
of	NULL
an	NULL
Alu	NULL
repeat	NULL
is	NULL
adjacent	NULL
to	NULL
the	NULL
minimal	NULL
enhancer	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
CD8a	NULL
«	NULL
enhancer	NULL
described	NULL
in	NULL
this	NULL
study	NULL
is	NULL
a	NULL
complex	NULL
transcriptional	NULL
regulatory	NULL
element	NULL
that	NULL
potentially	NULL
contributes	NULL
to	NULL
the	NULL
T-cell	NULL
specificity	NULL
of	NULL
human	NULL
CD8a	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
existence	NULL
of	NULL
an	NULL
Alu	NULL
repeat	NULL
within	NULL
the	NULL
enhancer	NULL
indicates	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
Alu	NULL
sequences	NULL
in	NULL
cell-specific	NULL
regulation	NULL
.	NULL

While	NULL
the	NULL
function	NULL
of	NULL
Alu	NULL
sequences	NULL
is	NULL
largely	NULL
unknown	NULL
,	NULL
there	NULL
are	NULL
accumulating	NULL
examples	NULL
of	NULL
their	NULL
role	NULL
in	NULL
gene	NULL
regulation	NULL
(	NULL
6	NULL
,	NULL
34	NULL
,	NULL
67	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
DNA-binding	NULL
proteins	NULL
are	NULL
known	NULL
to	NULL
bind	NULL
to	NULL
Alu	NULL
repeats	NULL
(	NULL
6	NULL
,	NULL
9	NULL
,	NULL
78	NULL
)	NULL
.	NULL

Some	NULL
characterized	NULL
regulatory	NULL
elements	NULL
,	NULL
such	NULL
as	NULL
a	NULL
positive	NULL
and	NULL
a	NULL
negative	NULL
element	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
y	NULL
chain	NULL
subunit	NULL
of	NULL
the	NULL
high-affinity	NULL
immunoglobulin	NULL
E	NULL
receptor	NULL
,	NULL
contain	NULL
parts	NULL
of	NULL
Alu	NULL
repeats	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
insertion	NULL
of	NULL
Alu	NULL
repeats	NULL
into	NULL
or	NULL
near	NULL
a	NULL
gene	NULL
,	NULL
such	NULL
as	NULL
occurred	NULL
in	NULL
the	NULL
CD8	NULL
gene	NULL
,	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
evolution	NULL
of	NULL
regulatory	NULL
elements	NULL
controlling	NULL
the	NULL
expression	NULL
of	NULL
that	NULL
gene	NULL
.	NULL

Because	NULL
Alu	NULL
repeats	NULL
are	NULL
found	NULL
only	NULL
in	NULL
primate	NULL
species	NULL
,	NULL
it	NULL
would	NULL
imply	NULL
that	NULL
the	NULL
existence	NULL
of	NULL
this	NULL
regulatory	NULL
element	NULL
within	NULL
the	NULL
CD8a	NULL
intron	NULL
would	NULL
be	NULL
restricted	NULL
to	NULL
primates	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
this	NULL
is	NULL
supported	NULL
by	NULL
sequence	NULL
comparisons	NULL
performed	NULL
between	NULL
human	NULL
and	NULL
murine	NULL
sequences	NULL
in	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
CD8a	NULL
gene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
which	NULL
showed	NULL
no	NULL
homology	NULL
in	NULL
the	NULL
region	NULL
of	NULL
the	NULL
human	NULL
enhancer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
searched	NULL
the	NULL
murine	NULL
intron	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
protein	NULL
binding	NULL
motifs	NULL
that	NULL
we	NULL
found	NULL
in	NULL
the	NULL
human	NULL
intron	NULL
and	NULL
did	NULL
not	NULL
find	NULL
any	NULL
of	NULL
these	NULL
sites	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
insertion	NULL
of	NULL
the	NULL
Alu	NULL
sequences	NULL
apparently	NULL
contributed	NULL
to	NULL
the	NULL
evolution	NULL
of	NULL
this	NULL
regulatory	NULL
element	NULL
.	NULL

A	NULL
detailed	NULL
comparison	NULL
of	NULL
all	NULL
the	NULL
characterized	NULL
T-cell-specific	NULL
enhancers	NULL
,	NULL
including	NULL
the	NULL
human	NULL
CD8a	NULL
«	NULL
enhancer	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
,	NULL
revealed	NULL
that	NULL
many	NULL
are	NULL
patchwork	NULL
composed	NULL
of	NULL
a	NULL
mutual	NULL
set	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
for	NULL
GATA	NULL
,	NULL
TCF	NULL
,	NULL
Ets	NULL
,	NULL
CREB/ATF	NULL
,	NULL
and	NULL
bHLH	NULL
proteins	NULL
(	NULL
20	NULL
,	NULL
23	NULL
,	NULL
31	NULL
,	NULL
38	NULL
,	NULL
41	NULL
,	NULL
44	NULL
,	NULL
45	NULL
,	NULL
50	NULL
,	NULL
51	NULL
,	NULL
64-66	NULL
,	NULL
74	NULL
,	NULL
76	NULL
,	NULL
81	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
a	NULL
consortium	NULL
of	NULL
a	NULL
relatively	NULL
limited	NULL
number	NULL
of	NULL
7068	NULL
HAMBOR	NULL
ET	NULL
AL	NULL
.	NULL

transcription	NULL
factors	NULL
,	NULL
many	NULL
exclusively	NULL
found	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
may	NULL
coordinately	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
T-cell	NULL
genes	NULL
.	NULL

Although	NULL
tied	NULL
together	NULL
by	NULL
this	NULL
common	NULL
thread	NULL
,	NULL
each	NULL
regulatory	NULL
region	NULL
is	NULL
organized	NULL
into	NULL
a	NULL
unique	NULL
pattern	NULL
of	NULL
cis-acting	NULL
elements	NULL
.	NULL

Cross-talk	NULL
amongst	NULL
an	NULL
assemblage	NULL
of	NULL
trans-acting	NULL
factors	NULL
,	NULL
determined	NULL
to	NULL
a	NULL
certain	NULL
extent	NULL
by	NULL
the	NULL
geometric	NULL
spacing	NULL
of	NULL
the	NULL
cis	NULL
elements	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
interaction	NULL
affinity	NULL
of	NULL
each	NULL
cis	NULL
element	NULL
with	NULL
related	NULL
or	NULL
posttran-scriptionally	NULL
modified	NULL
members	NULL
of	NULL
an	NULL
individual	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
,	NULL
could	NULL
ultimately	NULL
influence	NULL
the	NULL
temporal	NULL
and	NULL
spatial	NULL
expression	NULL
of	NULL
individual	NULL
T-cell-specific	NULL
genes	NULL
and	NULL
potentiate	NULL
differential	NULL
gene	NULL
expression	NULL
during	NULL
T-cell	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
the	NULL
relative	NULL
location	NULL
of	NULL
TCF-1	NULL
,	NULL
a	NULL
protein	NULL
capable	NULL
of	NULL
bending	NULL
DNA	NULL
(	NULL
22	NULL
)	NULL
,	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
determining	NULL
what	NULL
types	NULL
of	NULL
protein-protein	NULL
interactions	NULL
may	NULL
occur	NULL
within	NULL
an	NULL
enhancer	NULL
.	NULL

While	NULL
the	NULL
importance	NULL
of	NULL
some	NULL
motifs	NULL
such	NULL
as	NULL
GATA-3	NULL
and	NULL
Ets-1	NULL
were	NULL
apparent	NULL
from	NULL
single-site	NULL
mutations	NULL
,	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
binding	NULL
motifs	NULL
for	NULL
the	NULL
LyF-1	NULL
,	NULL
TCF-1	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
bHLH	NULL
nucleoproteins	NULL
only	NULL
became	NULL
apparent	NULL
when	NULL
mutations	NULL
in	NULL
these	NULL
sites	NULL
were	NULL
analyzed	NULL
in	NULL
pairs	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
the	NULL
CD8a	NULL
enhancer	NULL
,	NULL
like	NULL
other	NULL
T-cell-specific	NULL
enhancers	NULL
,	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
set	NULL
of	NULL
partially	NULL
redundant	NULL
cis-acting	NULL
elements	NULL
which	NULL
are	NULL
able	NULL
to	NULL
compensate	NULL
for	NULL
the	NULL
functional	NULL
loss	NULL
of	NULL
other	NULL
individual	NULL
elements	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
these	NULL
individual	NULL
elements	NULL
may	NULL
change	NULL
during	NULL
T-cell	NULL
differentiation	NULL
or	NULL
activation	NULL
,	NULL
since	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
genes	NULL
for	NULL
these	NULL
lymphoid-restricted	NULL
transcription	NULL
factors	NULL
are	NULL
first	NULL
expressed	NULL
at	NULL
different	NULL
periods	NULL
of	NULL
thymocyte	NULL
development	NULL
(	NULL
10	NULL
,	NULL
45	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Since	NULL
we	NULL
have	NULL
thus	NULL
far	NULL
characterized	NULL
previously	NULL
described	NULL
protein	NULL
binding	NULL
motifs	NULL
,	NULL
the	NULL
existence	NULL
of	NULL
additional	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
CD8a	NULL
«	NULL
enhancer	NULL
remains	NULL
a	NULL
distinct	NULL
possibil-ity	NULL
.	NULL

Indeed	NULL
,	NULL
preliminary	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
allowed	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
protected	NULL
region	NULL
close	NULL
to	NULL
,	NULL
but	NULL
not	NULL
encompassing	NULL
,	NULL
the	NULL
TCF-1	NULL
consensus	NULL
motif	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
the	NULL
best	NULL
of	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
sequence	NULL
does	NULL
not	NULL
conform	NULL
to	NULL
any	NULL
previously	NULL
described	NULL
cis-acting	NULL
element	NULL
and	NULL
therefore	NULL
may	NULL
represent	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
novel	NULL
transacting	NULL
factor	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
properties	NULL
of	NULL
a	NULL
CD8a	NULL
«	NULL
enhancer	NULL
that	NULL
is	NULL
active	NULL
in	NULL
all	NULL
T-cell	NULL
lines	NULL
tested	NULL
,	NULL
including	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
,	NULL
which	NULL
does	NULL
not	NULL
express	NULL
the	NULL
endogenous	NULL
CD8	NULL
«	NULL
gene	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
intronic	NULL
region	NULL
containing	NULL
the	NULL
CD8a	NULL
«	NULL
enhancer	NULL
is	NULL
hypersensitive	NULL
to	NULL
DNase	NULL
I	NULL
digestion	NULL
in	NULL
Jurkat	NULL
cells	NULL
suggests	NULL
that	NULL
this	NULL
enhancer	NULL
is	NULL
poised	NULL
to	NULL
receive	NULL
the	NULL
proper	NULL
trans-regulatory	NULL
information	NULL
.	NULL

While	NULL
it	NULL
is	NULL
unknown	NULL
why	NULL
Jurkat	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
their	NULL
endogenous	NULL
CD8a	NULL
gene	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
enhancer	NULL
in	NULL
Jurkat	NULL
cells	NULL
may	NULL
reflect	NULL
an	NULL
abnormal	NULL
property	NULL
of	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

It	NULL
is	NULL
plausible	NULL
that	NULL
the	NULL
endogenous	NULL
CD8a	NULL
enhancer	NULL
or	NULL
some	NULL
other	NULL
important	NULL
endogenous	NULL
regulatory	NULL
region	NULL
(	NULL
such	NULL
as	NULL
the	NULL
promoter	NULL
)	NULL
is	NULL
defective	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
CD8a	NULL
enhancer	NULL
may	NULL
be	NULL
inactivated	NULL
by	NULL
a	NULL
negative	NULL
regulator	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
adjoining	NULL
silencer	NULL
element	NULL
,	NULL
which	NULL
is	NULL
missing	NULL
in	NULL
the	NULL
reporter-based	NULL
plasmids	NULL
.	NULL

The	NULL
latter	NULL
possibility	NULL
is	NULL
particularly	NULL
appealing	NULL
,	NULL
since	NULL
an	NULL
additional	NULL
silencer	NULL
element	NULL
outside	NULL
of	NULL
the	NULL
TCRa	NULL
enhancer	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
down-regulate	NULL
the	NULL
function	NULL
of	NULL
the	NULL
TCRa	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
of	NULL
the	NULL
y8	NULL
lineage	NULL
(	NULL
81	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
additional	NULL
cis-acting	NULL
elements	NULL
may	NULL
be	NULL
required	NULL
to	NULL
fine-tune	NULL
expression	NULL
of	NULL
the	NULL
CD8a	NULL
gene	NULL
in	NULL
specific	NULL
T-cell	NULL
subsets	NULL
.	NULL

While	NULL
this	NULL
initial	NULL
characterization	NULL
of	NULL
the	NULL
CD8a	NULL
«	NULL
intronic	NULL
enhancer	NULL
will	NULL
significantly	NULL
facilitate	NULL
future	NULL
studies	NULL
,	NULL
many	NULL
unanswered	NULL
questions	NULL
remain	NULL
.	NULL

What	NULL
is	NULL
the	NULL
nature	NULL
of	NULL
negative	NULL
regulation	NULL
during	NULL
selection	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
?	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

How	NULL
are	NULL
these	NULL
cis-acting	NULL
elements	NULL
able	NULL
to	NULL
mediate	NULL
temporal	NULL
signals	NULL
during	NULL
the	NULL
process	NULL
of	NULL
thymic	NULL
differentiation	NULL
?	NULL

Once	NULL
all	NULL
of	NULL
the	NULL
cis-regulatory	NULL
elements	NULL
have	NULL
been	NULL
identified	NULL
and	NULL
characterized	NULL
,	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
governing	NULL
CD8a	NULL
gene	NULL
expression	NULL
will	NULL
be	NULL
possible	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Sue	NULL
Williams	NULL
,	NULL
Mike	NULL
Fogliano	NULL
,	NULL
and	NULL
Laura	NULL
Elsenboss	NULL
for	NULL
sequencing	NULL
the	NULL
deletional	NULL
and	NULL
site-directed	NULL
mutants	NULL
;	NULL
John	NULL
Thompson	NULL
(	NULL
Pfizer	NULL
,	NULL
Inc.	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
plasmid	NULL
pLuxF47	NULL
;	NULL
David	NULL
Dean	NULL
for	NULL
densitometry	NULL
scanning	NULL
;	NULL
and	NULL
Mei-hua	NULL
Gao	NULL
,	NULL
Patricia	NULL
Giblin	NULL
,	NULL
Kevin	NULL
Ogborne	NULL
,	NULL
and	NULL
Lois	NULL
Nichols	NULL
for	NULL
valuable	NULL
advice	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Ian	NULL
Williams	NULL
and	NULL
Alan	NULL
Proctor	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
support	NULL
of	NULL
this	NULL
project	NULL
.	NULL

J.E.H	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
from	NULL
Pfizer	NULL
,	NULL
Inc.	NULL
P.K	NULL
.	NULL

is	NULL
a	NULL
scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aldrich	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
R.	NULL
E.	NULL
Hammer	NULL
,	NULL
S.	NULL
Jones-Youngblood	NULL
,	NULL
U.	NULL
Koszi-nowski	NULL
,	NULL
L.	NULL
Hood	NULL
,	NULL
I.	NULL
Stroynowski	NULL
,	NULL
and	NULL
J.	NULL
Forman	NULL
.	NULL

1991	NULL
.	NULL

Negative	NULL
and	NULL
positive	NULL
selection	NULL
of	NULL
antigen-specific	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
affected	NULL
by	NULL
the	NULL
«	NULL
3	NULL
domain	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:718-721	NULL
.	NULL

2	NULL
.	NULL

Aronow	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
R.	NULL
N.	NULL
Silbiger	NULL
,	NULL
M.	NULL
R.	NULL
Dusing	NULL
,	NULL
J.	NULL
L.	NULL
Stock	NULL
,	NULL
K.	NULL
L.	NULL
Yager	NULL
,	NULL
S.	NULL
Potter	NULL
,	NULL
J.	NULL
J.	NULL
Hutton	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Wiginton	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
adenosine	NULL
deaminase	NULL
gene	NULL
thymic	NULL
regulatory	NULL
region	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
generate	NULL
position-independent	NULL
transgene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4170-4185	NULL
.	NULL

3	NULL
.	NULL

Barber	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
J.	NULL
D.	NULL
Dasgupta	NULL
,	NULL
S.	NULL
F.	NULL
Schlossman	NULL
,	NULL
J.	NULL
M.	NULL
Trevil-lyan	NULL
,	NULL
and	NULL
C.	NULL
E.	NULL
Rudd	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
CD4	NULL
and	NULL
CD8	NULL
antigens	NULL
are	NULL
coupled	NULL
to	NULL
a	NULL
protein-tyrosine	NULL
kinase	NULL
(	NULL
pS56	NULL
``	NULL
*	NULL
)	NULL
that	NULL
phosphorylates	NULL
the	NULL
CD3	NULL
complex	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:3277-3281	NULL
.	NULL

4	NULL
.	NULL

Bier	NULL
,	NULL
E.	NULL
,	NULL
Y.	NULL
Hashimoto	NULL
,	NULL
M.	NULL
I.	NULL
Greene	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Maxam	NULL
.	NULL

1985	NULL
.	NULL

Active	NULL
T-cell	NULL
receptor	NULL
genes	NULL
have	NULL
intron	NULL
deoxyribonuclease	NULL
hypersensitive	NULL
sites	NULL
.	NULL

Science	NULL
229:528-534	NULL
.	NULL

5	NULL
.	NULL

Bories	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
P.	NULL
Loiseau	NULL
,	NULL
L.	NULL
d'Auriol	NULL
,	NULL
C.	NULL
Gontier	NULL
,	NULL
A.	NULL
Bensussan	NULL
,	NULL
L.	NULL
Degos	NULL
,	NULL
and	NULL
F.	NULL
Sigaux	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
8	NULL
chain	NULL
gene	NULL
.	NULL

A	NULL
T	NULL
lineage-specific	NULL
enhancer	NULL
element	NULL
is	NULL
located	NULL
in	NULL
the	NULL
J8-C38	NULL
intron	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:75-83	NULL
.	NULL

6	NULL
.	NULL

Brini	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
G.	NULL
M.	NULL
Lee	NULL
,	NULL
and	NULL
J.-P.	NULL
Kinet	NULL
.	NULL

1993	NULL
.	NULL

Involvement	NULL
of	NULL
Alu	NULL
sequences	NULL
in	NULL
the	NULL
cell-specific	NULL
regulation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
y	NULL
chain	NULL
of	NULL
Fc	NULL
and	NULL
T	NULL
cell	NULL
receptors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:1355-1361	NULL
.	NULL

7	NULL
.	NULL

Bruns	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Kavathas	NULL
,	NULL
Y.	NULL
Shiloh	NULL
,	NULL
K.	NULL
Sakai	NULL
,	NULL
J.	NULL
Schwaber	NULL
,	NULL
S.	NULL
A.	NULL
Latt	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
human	NULL
T	NULL
cell	NULL
antigen	NULL
Leu-2	NULL
(	NULL
T8	NULL
)	NULL
is	NULL
encoded	NULL
on	NULL
chromosome	NULL
2	NULL
.	NULL

Human	NULL
Genet	NULL
.	NULL

70:311-314	NULL
.	NULL

8	NULL
.	NULL

Chalupny	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
and	NULL
P.	NULL
Kavathas	NULL
.	NULL

1991	NULL
.	NULL

Association	NULL
of	NULL
CD8	NULL
with	NULL
p56	NULL
``	NULL
is	NULL
required	NULL
for	NULL
early	NULL
T	NULL
cell	NULL
signalling	NULL
events	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1201-1207	NULL
.	NULL

9	NULL
.	NULL

Chesnokov	NULL
,	NULL
I.	NULL
,	NULL
V.	NULL
Bozhkov	NULL
,	NULL
B.	NULL
Popov	NULL
,	NULL
and	NULL
N.	NULL
Tomilin	NULL
.	NULL

1991	NULL
.	NULL

Binding	NULL
specificity	NULL
of	NULL
human	NULL
nuclear	NULL
protein	NULL
interacting	NULL
with	NULL
the	NULL
Alu-family	NULL
DNA	NULL
repeats	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

178:613-619	NULL
.	NULL

10	NULL
.	NULL

Clevers	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1991	NULL
.	NULL

Towards	NULL
a	NULL
molecular	NULL
understanding	NULL
of	NULL
T-cell	NULL
differentiation	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
12:86	NULL
92	NULL
.	NULL

11	NULL
.	NULL

Comb	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
C.	NULL
Birnberg	NULL
,	NULL
A.	NULL
Seasholtz	NULL
,	NULL
E.	NULL
Herbert	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Goodman	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
cAMP	NULL
and	NULL
phorbol	NULL
ester	NULL
inducible	NULL
DNA	NULL
binding	NULL
element	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323:353-356	NULL
.	NULL

12	NULL
.	NULL

Connolly	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
T.	NULL
A.	NULL
Potter	NULL
,	NULL
E.	NULL
M.	NULL
Wormstall	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Hansen	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
Lyt-2	NULL
molecule	NULL
recognizes	NULL
residues	NULL
in	NULL
the	NULL
class	NULL
I	NULL
a3	NULL
domain	NULL
in	NULL
allogeneic	NULL
cytotoxic	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168:325-341	NULL
.	NULL

13.	NULL
deWet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
K.	NULL
V.	NULL
Wood	NULL
,	NULL
M.	NULL
DeLuca	NULL
,	NULL
D.	NULL
R.	NULL
Helinski	NULL
,	NULL
and	NULL
S.	NULL
Subramani	NULL
.	NULL

1987	NULL
.	NULL

Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:725-737	NULL
.	NULL

14	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
HI	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Enver	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Raich	NULL
,	NULL
A.	NULL
J.	NULL
Ebens	NULL
,	NULL
T.	NULL
Papayannopoulou	NULL
,	NULL
F.	NULL
Constantini	NULL
,	NULL
and	NULL
G.	NULL
Stamatoyannopoulos	NULL
.	NULL

1990	NULL
.	NULL

Developmental	NULL
regulation	NULL
of	NULL
human	NULL
fetal-to-adult	NULL
globin	NULL
gene	NULL
switching	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:309-313	NULL
.	NULL

Eustice	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
P.	NULL
A.	NULL
Feldman	NULL
,	NULL
A.	NULL
M.	NULL
Colberg-Poley	NULL
,	NULL
R.	NULL
M.	NULL
Buckery	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Neubauer	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
sensitive	NULL
method	NULL
for	NULL
detection	NULL
of	NULL
B-galactosidase	NULL
in	NULL
transfected	NULL
mammalian	NULL
cells	NULL
.	NULL

BioTechniques	NULL
11:739-742	NULL
.	NULL

Faisst	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
S.	NULL
Meyer	NULL
.	NULL

1992	NULL
.	NULL

Compilation	NULL
of	NULL
vertebrate-encoded	NULL
transcription	NULL
factors	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:3-26	NULL
.	NULL

Fried	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Crother	NULL
.	NULL

1984	NULL
.	NULL

Equilibrium	NULL
and	NULL
kinetics	NULL
of	NULL
lac	NULL
repressor-operator	NULL
interactions	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

172:263-282	NULL
.	NULL

Fung-Leung	NULL
,	NULL
W.	NULL
,	NULL
M.	NULL
W.	NULL
Schilham	NULL
,	NULL
A.	NULL
Rabemtulla	NULL
,	NULL
T.	NULL
M.	NULL
Kun-dig	NULL
,	NULL
M.	NULL
Vollenweider	NULL
,	NULL
J.	NULL
Potter	NULL
,	NULL
W.	NULL
van	NULL
Ewijk	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1991	NULL
.	NULL

CD8	NULL
is	NULL
needed	NULL
for	NULL
development	NULL
of	NULL
cytotoxic	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
helper	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
6§:443-449.	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
Galson	NULL
,	NULL
and	NULL
C.	NULL
Terhorst	NULL
.	NULL

1990	NULL
.	NULL

Tissue	NULL
specific	NULL
nuclear	NULL
factors	NULL
mediate	NULL
expression	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:109-115	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Morgan	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Moore	NULL
.	NULL

1992	NULL
.	NULL

Functionally	NULL
distinct	NULL
isoforms	NULL
of	NULL
the	NULL
CRE-BP	NULL
DNA-binding	NULL
protein	NULL
mediate	NULL
activity	NULL
of	NULL
a	NULL
T-cell	NULL
specific	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:747-757	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Cox	NULL
,	NULL
and	NULL
R.	NULL
Grossched	NULL
]	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
HMG	NULL
domain	NULL
of	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
bends	NULL
DNA	NULL
and	NULL
facilitates	NULL
assembly	NULL
of	NULL
functional	NULL
nucleoprotein	NULL
structures	NULL
.	NULL

Cell	NULL
69:185-195	NULL
.	NULL

Gill	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
D.	NULL
Zaninetta	NULL
,	NULL
and	NULL
K.	NULL
Karjalainen	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
transcriptional	NULL
enhancer	NULL
of	NULL
the	NULL
mouse	NULL
T	NULL
cell	NULL
receptor	NULL
8	NULL
gene	NULL
locus	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21:807-810	NULL
.	NULL

Glassy	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
H.	NULL
H.	NULL
Handley	NULL
,	NULL
H.	NULL
Hagiwara	NULL
,	NULL
and	NULL
I.	NULL
Royston	NULL
.	NULL

1983	NULL
.	NULL

UC	NULL
729-6	NULL
,	NULL
a	NULL
human	NULL
lymphoblastoid	NULL
B-cell	NULL
line	NULL
useful	NULL
for	NULL
generating	NULL
antibody-secreting	NULL
human-human	NULL
hybridomas	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:6327-6331.	NULL
.	NULL

Gorman	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Y.	NULL
H.	NULL
Sun	NULL
,	NULL
R.	NULL
Zamoyska	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Parnes	NULL
.	NULL

1988	NULL
.	NULL

Molecular	NULL
linkage	NULL
of	NULL
the	NULL
Ly-3	NULL
and	NULL
Ly-2	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:3646-3653	NULL
.	NULL

Greaves	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
F.	NULL
D.	NULL
Wilson	NULL
,	NULL
G.	NULL
Lang	NULL
,	NULL
and	NULL
D.	NULL
Kioussis	NULL
.	NULL

1989	NULL
.	NULL

Human	NULL
CD2	NULL
3'-flanking	NULL
sequences	NULL
confer	NULL
high-level	NULL
,	NULL
T	NULL
cell-specific	NULL
,	NULL
position-independent	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
56:979-986	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
and	NULL
W.	NULL
T.	NULL
Garrard	NULL
.	NULL

1988	NULL
.	NULL

Nuclease	NULL
hypersensitive	NULL
sites	NULL
in	NULL
chromatin	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

57:159-197.	NULL
.	NULL

Halazonetis	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
and	NULL
A.	NULL
N.	NULL
Kandil	NULL
.	NULL

1992	NULL
.	NULL

Predicted	NULL
structural	NULL
similarities	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
bHLH	NULL
proteins	NULL
and	NULL
endonuclease	NULL
EcoRI	NULL
.	NULL

Science	NULL
255:464-466	NULL
.	NULL

Hanke	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
L.	NULL
N.	NULL
Nichols	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Coon	NULL
.	NULL

1992	NULL
.	NULL

FK506	NULL
and	NULL
rapamycin	NULL
selectively	NULL
enhance	NULL
degradation	NULL
of	NULL
IL-2	NULL
and	NULL
GM-CSF	NULL
mRNA	NULL
.	NULL

Lymphokine	NULL
Cytokine	NULL
Res	NULL
.	NULL

11:221-231	NULL
.	NULL

Hashimoto	NULL
,	NULL
Y	NULL
.	NULL

1989	NULL
.	NULL

T	NULL
cell	NULL
receptor	NULL
B	NULL
gene	NULL
has	NULL
two	NULL
downstream	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
regions	NULL
.	NULL

Possible	NULL
mechanisms	NULL
of	NULL
tissue-and	NULL
stage-specific	NULL
gene	NULL
regulation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169:2097-2107	NULL
.	NULL

Hashimoto	NULL
,	NULL
Y.	NULL
,	NULL
A.	NULL
M.	NULL
Maxam	NULL
,	NULL
and	NULL
M.	NULL
I.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
tissue	NULL
specific	NULL
nuclear	NULL
proteins	NULL
:	NULL
DNA	NULL
sequence	NULL
and	NULL
protein	NULL
binding	NULL
regions	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
beta	NULL
J-C	NULL
intron	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:3027-3033	NULL
.	NULL

Haynes	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
S.	NULL
M.	NULL
Denning	NULL
,	NULL
K.	NULL
H.	NULL
Singer	NULL
,	NULL
and	NULL
J.	NULL
Kurtzberg	NULL
.	NULL

1989	NULL
.	NULL

Ontogeny	NULL
of	NULL
T-cell	NULL
precursors	NULL
:	NULL
a	NULL
model	NULL
for	NULL
the	NULL
initial	NULL
stages	NULL
of	NULL
human	NULL
T-cell	NULL
development	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10:87-91	NULL
.	NULL

Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
W.	NULL
G.	NULL
Wood	NULL
,	NULL
A.	NULL
P.	NULL
Jarman	NULL
,	NULL
J.	NULL
Sharpe	NULL
,	NULL
J.	NULL
Lida	NULL
,	NULL
I.-M.	NULL
Pretorius	NULL
,	NULL
and	NULL
H.	NULL
Ayyub	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
major	NULL
positive	NULL
regulatory	NULL
region	NULL
located	NULL
far	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
«	NULL
-globin	NULL
gene	NULL
locus	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1588-1601	NULL
.	NULL

Howard	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
and	NULL
K.	NULL
Sakamoto	NULL
.	NULL

1990	NULL
.	NULL

Alu	NULL
interspersed	NULL
repeats	NULL
:	NULL
selfish	NULL
DNA	NULL
or	NULL
a	NULL
functional	NULL
gene	NULL
family	NULL
?	NULL

New	NULL
Biol	NULL
.	NULL

2:759-770	NULL
.	NULL

Ingold	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
C.	NULL
Landel	NULL
,	NULL
C.	NULL
Knail	NULL
,	NULL
G.	NULL
A.	NULL
Evens	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Potter	NULL
.	NULL

1991	NULL
.	NULL

Co-engagement	NULL
of	NULL
CD8	NULL
with	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
is	NULL
required	NULL
for	NULL
negative	NULL
selection	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:721-723	NULL
.	NULL

Jarry	NULL
,	NULL
A.	NULL
,	NULL
N.	NULL
Cerf-Bensussan	NULL
,	NULL
N.	NULL
Brousee	NULL
,	NULL
F.	NULL
Selz	NULL
,	NULL
and	NULL
D.	NULL
Guy-Grand	NULL
.	NULL

1990	NULL
.	NULL

Subsets	NULL
of	NULL
CD3*	NULL
(	NULL
T	NULL
cell	NULL
receptor	NULL
o/B	NULL
or	NULL
4/8	NULL
)	NULL
and	NULL
CD3~	NULL
lymphocytes	NULL
isolated	NULL
from	NULL
normal	NULL
human	NULL
gut	NULL
epithe-	NULL
Alu-CONTAINING	NULL
T-CELL-SPECIFIC	NULL
CD8	NULL
«	NULL
ENHANCER	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

7069	NULL
lium	NULL
display	NULL
phenotypical	NULL
features	NULL
different	NULL
from	NULL
their	NULL
counterparts	NULL
in	NULL
peripheral	NULL
blood	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:1097-1103	NULL
.	NULL

Joulin	NULL
,	NULL
V.	NULL
,	NULL
D.	NULL
Bories	NULL
,	NULL
J.-F.	NULL
Eleouet	NULL
,	NULL
M.-C.	NULL
Labastie	NULL
,	NULL
S.	NULL
Chretien	NULL
,	NULL
M.-G.	NULL
Mattei	NULL
,	NULL
and	NULL
P.-H.	NULL
Romeo	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
T-cell	NULL
specific	NULL
TCR	NULL
8	NULL
DNA	NULL
binding	NULL
protein	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
human	NULL
GATA	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1809-1816	NULL
.	NULL

Kappes	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
P.	NULL
Browne	NULL
,	NULL
and	NULL
S.	NULL
Tonegawa	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
at	NULL
the	NULL
locus	NULL
encoding	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
y	NULL
chain	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:2204-2208	NULL
.	NULL

Karpinski	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
G.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
Huggenvik	NULL
,	NULL
M.	NULL
D.	NULL
Uhler	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
human	NULL
CREB-2	NULL
:	NULL
and	NULL
ATF/CREB	NULL
transcription	NULL
factor	NULL
that	NULL
can	NULL
negatively	NULL
regulate	NULL
transcription	NULL
from	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:4820-4824.	NULL
.	NULL

Kavathas	NULL
,	NULL
P.	NULL
,	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Parnes	NULL
.	NULL

1984	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
human	NULL
T-lymphocyte	NULL
differentiation	NULL
antigen	NULL
Leu-2	NULL
(	NULL
T8	NULL
)	NULL
by	NULL
gene	NULL
transfer	NULL
and	NULL
cDNA	NULL
subtraction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:7688-7692	NULL
.	NULL

Krimpenfort	NULL
,	NULL
P.	NULL
,	NULL
R.	NULL
de	NULL
Jong	NULL
,	NULL
Y.	NULL
Uematsu	NULL
,	NULL
Z.	NULL
Dembic	NULL
,	NULL
S.	NULL
Ryser	NULL
,	NULL
H.	NULL
von	NULL
Boehmer	NULL
,	NULL
M.	NULL
Steinmetz	NULL
,	NULL
and	NULL
A.	NULL
Berns	NULL
.	NULL

1988	NULL
.	NULL

Transcription	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
B-chain	NULL
genes	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
downstream	NULL
regulatory	NULL
element	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:745-750	NULL
.	NULL

Kunkel	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1985	NULL
.	NULL

Rapid	NULL
and	NULL
efficient	NULL
site-specific	NULL
mutagenesis	NULL
without	NULL
phenotypic	NULL
selection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:488-492	NULL
.	NULL

Landschultz	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
P.	NULL
F.	NULL
Johnson	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
leucine	NULL
zipper	NULL
:	NULL
a	NULL
hypothetical	NULL
structure	NULL
common	NULL
to	NULL
a	NULL
new	NULL
class	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
240:1759-1764.	NULL
.	NULL

Lee	NULL
,	NULL
M.-R.	NULL
,	NULL
C.-S.	NULL
Chung	NULL
,	NULL
M.-L.	NULL
Liou	NULL
,	NULL
M.	NULL
Wu	NULL
,	NULL
W.-F.	NULL
Li	NULL
,	NULL
Y.-P.	NULL
Hsueh	NULL
,	NULL
and	NULL
M.~Z	NULL
.	NULL

Lai	NULL
.	NULL

1992	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
T	NULL
cell	NULL
receptor	NULL
VB	NULL
decamer	NULL
motif	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1906-1912	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
1992	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
during	NULL
T-cell	NULL
development	NULL
:	NULL
the	NULL
«	NULL
TCR	NULL
gene	NULL
as	NULL
a	NULL
molecular	NULL
model	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:22-30.	NULL
.	NULL

Littman	NULL
,	NULL
D.	NULL
R.	NULL
1987	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
CD4	NULL
and	NULL
CD8	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

5:561-584	NULL
.	NULL

Lo	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
R.	NULL
Landau	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Smale	NULL
.	NULL

1991	NULL
.	NULL

LyF-l	NULL
,	NULL
a	NULL
transcriptional	NULL
regulator	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
novel	NULL
class	NULL
of	NULL
promoters	NULL
for	NULL
Iymphocyte-specific	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
:	NULL
5229-5243.	NULL
.	NULL

Luckow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
G.	NULL
Schutz	NULL
.	NULL

1987	NULL
.	NULL

CAT	NULL
constructions	NULL
with	NULL
multiple	NULL
unique	NULL
restriction	NULL
sites	NULL
for	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
regulatory	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:5490	NULL
.	NULL

MacGregor	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
C.	NULL
T.	NULL
Caskey	NULL
.	NULL

1989	NULL
.	NULL

Construction	NULL
of	NULL
plasmids	NULL
that	NULL
express	NULL
E.	NULL
coli	NULL
B-galactosidase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:2365	NULL
.	NULL

Mauxion	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
G.	NULL
Pray	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1990	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
sequences	NULL
within	NULL
the	NULL
JB2-CB2	NULL
intron	NULL
of	NULL
the	NULL
murine	NULL
T	NULL
cell	NULL
receptor	NULL
B-chain	NULL
gene	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:1577-1582	NULL
.	NULL

McDougall	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
L.	NULL
Peterson	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
transcriptional	NULL
enhancer	NULL
3	NULL
'	NULL
of	NULL
CB2	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
B	NULL
locus	NULL
.	NULL

Science	NULL
241:205-208	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
R.	NULL
Kingsbury	NULL
.	NULL

1982	NULL
.	NULL

Transcriptional	NULL
control	NULL
signals	NULL
of	NULL
a	NULL
eukaryotic	NULL
protein-coding	NULL
gene	NULL
.	NULL

Science	NULL
217:316-324	NULL
.	NULL

Minowada	NULL
,	NULL
J	NULL
.	NULL

1988	NULL
.	NULL

Leukemia	NULL
cell	NULL
lines	NULL
.	NULL

Cancer	NULL
Rev	NULL
.	NULL

10:1-18	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Schonleber	NULL
,	NULL
P.	NULL
McCaw	NULL
,	NULL
H.	NULL
Vaessin	NULL
,	NULL
M.	NULL
Caudy	NULL
,	NULL
L.	NULL
Y.	NULL
Jan	NULL
,	NULL
C.	NULL
V.	NULL
Cabrera	NULL
,	NULL
J.	NULL
Buskin	NULL
,	NULL
S.	NULL
D.	NULL
Hauschka	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Lassar	NULL
,	NULL
H.	NULL
Weintraub	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

Interactions	NULL
between	NULL
heterologous	NULL
helix-loop-helix	NULL
proteins	NULL
generate	NULL
complexes	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
a	NULL
common	NULL
DNA	NULL
sequence	NULL
.	NULL

Cell	NULL
58:537-544	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Schonleber-McCaw	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
myc	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777-783	NULL
.	NULL

Nakayama	NULL
,	NULL
K.-I	NULL
.	NULL

,	NULL
Y.	NULL
Kawachi	NULL
,	NULL
S.	NULL
Tokito	NULL
,	NULL
N.	NULL
Minami	NULL
,	NULL
R.	NULL
Ya-mamoto	NULL
,	NULL
T.	NULL
Imai	NULL
,	NULL
G.	NULL
Gachelin	NULL
,	NULL
and	NULL
H.	NULL
Nakauchi	NULL
.	NULL

1992	NULL
.	NULL

Recent	NULL
duplication	NULL
of	NULL
the	NULL
two	NULL
human	NULL
CD8	NULL
B-chain	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1919-1927	NULL
.	NULL

7070	NULL
57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

HAMBOR	NULL
ET	NULL
AL	NULL
.	NULL

Nakayama	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Tokito	NULL
,	NULL
K.	NULL
Okumura	NULL
,	NULL
and	NULL
H.	NULL
Nakauchi	NULL
.	NULL

1989	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
CD8a	NULL
chain	NULL
(	NULL
Leu-2/T8	NULL
)	NULL
.	NULL

Immunogenetics	NULL
30:393-397	NULL
.	NULL

Norment	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
second	NULL
subunit	NULL
of	NULL
CD8	NULL
is	NULL
expressed	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:3433-3439	NULL
.	NULL

Norment	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
N.	NULL
Lonberg	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1989	NULL
.	NULL

Alternatively	NULL
spliced	NULL
mRNA	NULL
encodes	NULL
a	NULL
secreted	NULL
form	NULL
of	NULL
human	NULL
CD8a	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:3312-3319	NULL
.	NULL

Norment	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
R.	NULL
D.	NULL
Salter	NULL
,	NULL
P.	NULL
Parham	NULL
,	NULL
V.	NULL
H.	NULL
Engelhard	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1988	NULL
.	NULL

Cell-cell	NULL
adhesion	NULL
mediated	NULL
by	NULL
CD8	NULL
and	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
336:79-81	NULL
.	NULL

Olson	NULL
,	NULL
E.	NULL
N.	NULL
1990	NULL
.	NULL

MyoD	NULL
family	NULL
:	NULL
a	NULL
paradigm	NULL
for	NULL
development	NULL
?	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1454-1461	NULL
.	NULL

Parnes	NULL
,	NULL
J.	NULL
R.	NULL
1989	NULL
.	NULL

Molecular	NULL
biology	NULL
and	NULL
function	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

44:265-311	NULL
.	NULL

Potter	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
T.	NULL
V.	NULL
Rajan	NULL
,	NULL
R.	NULL
F.	NULL
Dick	NULL
II	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1989	NULL
.	NULL

Substitution	NULL
at	NULL
residue	NULL
227	NULL
of	NULL
H-2	NULL
class	NULL
I	NULL
molecules	NULL
abrogates	NULL
recognition	NULL
by	NULL
CD8-dependent	NULL
,	NULL
but	NULL
not	NULL
CD8-indepen-dent	NULL
,	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
337:73-75.	NULL
.	NULL

Prosser	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

Lake	NULL
,	NULL
D.	NULL
Wotton	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
transcriptional	NULL
enhancer	NULL
if	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
B	NULL
gene	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21:161-166	NULL
.	NULL

Prosser	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
D.	NULL
Wotton	NULL
,	NULL
A.	NULL
Gegonne	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
phorbol	NULL
ester	NULL
response	NULL
element	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
B-chain	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:9934-9938	NULL
.	NULL

Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
J.	NULL
F.	NULL
Pfohl	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Krangle	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
essential	NULL
site	NULL
for	NULL
transcriptional	NULL
activation	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
8	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5671-5680	NULL
.	NULL

Saffer	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Thurston	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
negative	NULL
regulatory	NULL
element	NULL
with	NULL
properties	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
enhancers	NULL
is	NULL
contained	NULL
within	NULL
an	NULL
Alu	NULL
sequence	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:355-364	NULL
.	NULL

Salter	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
R.	NULL
J.	NULL
Benjamin	NULL
,	NULL
P.	NULL
K.	NULL
Wesley	NULL
,	NULL
S.	NULL
E.	NULL
Buxton	NULL
,	NULL
T.	NULL
P.	NULL
J.	NULL
Garrett	NULL
,	NULL
C.	NULL
Clayberger	NULL
,	NULL
A.	NULL
M.	NULL
Krensky	NULL
,	NULL
A.	NULL
M.	NULL
Norment	NULL
,	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
and	NULL
P.	NULL
Parkam	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
T-cell	NULL
co-receptor	NULL
CD8	NULL
on	NULL
the	NULL
«	NULL
3	NULL
domain	NULL
of	NULL
HLA-A2	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
345:41-46	NULL
.	NULL

Sawada	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
1991	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
adjacent	NULL
to	NULL
the	NULL
murine	NULL
CD4	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5506-5515	NULL
.	NULL

Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
R.	NULL
D.	NULL
Newberry	NULL
,	NULL
D.	NULL
M.	NULL
Kranz	NULL
,	NULL
J.	NULL
H.	NULL
Russell	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Loh	NULL
.	NULL

1988	NULL
.	NULL

Selective	NULL
expression	NULL
of	NULL
an	NULL
antigen	NULL
receptor	NULL
on	NULL
CD8-bearing	NULL
T	NULL
lymphocytes	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
335:271-274	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

Shen	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
M.	NULL
A.	NULL
Batzer	NULL
,	NULL
and	NULL
P.	NULL
L.	NULL
Deininger	NULL
.	NULL

1991	NULL
.	NULL

Evolution	NULL
of	NULL
master	NULL
Alu	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Evol	NULL
.	NULL

33:311-320	NULL
.	NULL

Shiue	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
D.	NULL
Gorman	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Parnes	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
second	NULL
chain	NULL
of	NULL
human	NULL
CD8	NULL
is	NULL
expressed	NULL
on	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168:1993-2005	NULL
.	NULL

Southern	NULL
,	NULL
E.	NULL
M.	NULL
1975	NULL
.	NULL

Detection	NULL
of	NULL
specific	NULL
sequences	NULL
among	NULL
DNA	NULL
fragments	NULL
separated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

98:503-517	NULL
.	NULL

Spencer	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Y.-H.	NULL
Hsiang	NULL
,	NULL
J.	NULL
P.	NULL
Goldman	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
T-cell-specific	NULL
transcriptional	NULL
enhancer	NULL
located	NULL
3	NULL
'	NULL
of	NULL
Cyl	NULL
in	NULL
the	NULL
murine	NULL
T-cell	NULL
receptor	NULL
y	NULL
locus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:800-804	NULL
.	NULL

Swain	NULL
,	NULL
S	NULL
,	NULL
L.	NULL
1983	NULL
.	NULL

T	NULL
cell	NULL
subsets	NULL
and	NULL
recognition	NULL
of	NULL
MHC	NULL
class	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

74:129-142	NULL
.	NULL

Takeda	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Cheng	NULL
,	NULL
F.	NULL
Mauxion	NULL
,	NULL
C.	NULL
A.	NULL
Nelson	NULL
,	NULL
R.	NULL
D.	NULL
Newberry	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Loh	NULL
.	NULL

1990	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
murine	NULL
T-cell	NULL
receptor	NULL
B	NULL
enhancer	NULL
and	NULL
characteristics	NULL
of	NULL
its	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:5027-5035	NULL
.	NULL

Terry	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
J.	NULL
P.	NULL
DiSanto	NULL
,	NULL
T.	NULL
N.	NULL
Small	NULL
,	NULL
and	NULL
N.	NULL
Flomenberg	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
expression	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
CD8a	NULL
and	NULL
CD8	NULL
chains	NULL
.	NULL

Tissue	NULL
Antigens	NULL
35:82-91	NULL
.	NULL

Tomilin	NULL
,	NULL
N.	NULL
V.	NULL
,	NULL
V.	NULL
M.	NULL
Bozhkov	NULL
,	NULL
E.	NULL
M.	NULL
Bradbury	NULL
,	NULL
and	NULL
C.	NULL
W.	NULL
Schmid	NULL
.	NULL

1992	NULL
.	NULL

Differential	NULL
binding	NULL
of	NULL
human	NULL
nuclear	NULL
proteins	NULL
to	NULL
Alu	NULL
subfamilies	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:2941-2945.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Oosterwegal	NULL
,	NULL
D.	NULL
Dooijes	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
and	NULL
cloning	NULL
of	NULL
TCF-1	NULL
,	NULL
a	NULL
T	NULL
lympho-cyte-specific	NULL
transcription	NULL
factor	NULL
containing	NULL
sequence-specific	NULL
HMG	NULL
box	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:123-132	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Evolutionarily	NULL
conserved	NULL
Ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
:	NULL
1391-1399	NULL
.	NULL

Winoto	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989.	NULL
af	NULL
}	NULL
lineage-specific	NULL
expression	NULL
of	NULL
the	NULL
a	NULL
T	NULL
cell	NULL
receptor	NULL
gene	NULL
by	NULL
nearby	NULL
silencer	NULL
.	NULL

Cell	NULL
59:649-655	NULL
.	NULL

Wotton	NULL
,	NULL
D.	NULL
,	NULL
B.	NULL
F.	NULL
Flanagan	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1989	NULL
.	NULL

Chromatin	NULL
configuration	NULL
of	NULL
the	NULL
human	NULL
CD2	NULL
gene	NULL
locus	NULL
during	NULL
T-cell	NULL
development	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:4195-4199	NULL
.	NULL

Wu	NULL
,	NULL
C.	NULL
1980	NULL
.	NULL

The	NULL
5°	NULL
ends	NULL
of	NULL
drosophila	NULL
heat	NULL
shock	NULL
genes	NULL
in	NULL
chromatin	NULL
are	NULL
hypersensitive	NULL
to	NULL
DNase	NULL
I	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
286:854-860	NULL
.	NULL

Zuniga-Pflucker	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
L.	NULL
A.	NULL
Jones	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Kuisbeek	NULL
.	NULL

1990	NULL
.	NULL

CD8	NULL
is	NULL
required	NULL
during	NULL
positive	NULL
selection	NULL
of	NULL
CD4~/CD8+*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:427-437	NULL
.	NULL

